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Abstract 
Stromal interaction molecule (STIM)1 and 2 regulate agonist-induced and basal cytosolic 
calcium (Ca2+) levels through oligomerization and translocation to endoplasmic reticulum 
(ER)-plasma membrane (PM) junctions. At these junctions, the STIM cytosolic coiled-coil 
domains couple to PM Orai1 protein subunits to form Ca2+ released activated Ca2+ (CRAC) 
channels that facilitate store-operated Ca2+ entry (SOCE). One splice variant of STIM2, 
STIM2, contains an extra 8-residue (2β insert) located within the coiled-coils and inhibits 
SOCE through an unresolved mechanism, adding another layer of complexity to Ca2+ 
regulation in mammals. I hypothesize that the 2 insert perturbs the coiled-coil conformation 
and dynamics commensurate with an ability to activate SOCE. My data show the 2 insertion 
induced an overall reduction in -helicity, thermal stability, and promoted a conformation of 
greater exposed hydrophobicity which affected oligomerization. Previous studies show STIM2 
couples weakly to Orai1 compared to STIM1, and STIM2 is completely incapable of binding 
to Orai1. My functional studies show the 2 insertion in the STIM1 context also significantly 
inhibits SOCE. Therefore, my data suggests that the 2 insert inhibits STIM function and 
SOCE through a mechanism which perturbs -helical levels and destabilizes the cytosolic 
domain coiled-coil structure, independent of the requirement for weaker STIM2 coupling to 
Orai1. 
Keywords 
Stromal interaction molecule-1 (STIM1), stromal interaction molecule-2 (STIM2), store-
operated calcium entry (SOCE), calcium, alterative splicing, coiled-coil domains, stability 
oligomerization, Orai1, structure 
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Chapter 1 : Introduction 
1.1  Ionized calcium (Ca2+)  
1.1.1 A general overview of Ca2+ in physiological functions 
Ca2+ ions are essential factors for a myriad of physiological processes. While a majority of 
Ca2+ is used for bone remodeling and dental enamel formation during development, a small 
fraction of total body Ca2+ is reserved for critical cell signaling and metabolic functions 
such as muscle contraction, intracellular signaling, and neural transmissions, to name a 
few. In synaptic transmissions Ca2+ ions play a role in transducing action potentials into a 
chemical signal through the rise of cytosolic Ca2+ concentrations from the extracellular 
medium through voltage-gated Ca2+ channels. The rise of localized Ca2+ within the cytosol 
of axons,  permit neurotransmitter packaged vesicles to undergo exocytosis, allowing them 
to bind to postsynaptic receptors which further propagate the neural signal (Augustine, 
2001). Interestingly, proteins that interact with Ca2+ often have a helix-loop-helix structural 
motif known as the “EF-hand” which functions as an intracellular Ca2+ receptor that elicits 
a downstream response; the downstream response is typically dependent on a 
conformational change within the EF-hand (Ikura, 1996). One such example occurs during 
muscle contraction in skeletal muscles, where depolarization of the t-tubule membranes 
results in Ca2+ release from the sarcoplasmic reticulum (SR). The released Ca2+ binds to 
troponin C, one of three troponin subunits which interact (Herzberg et al., 1986). Troponin 
T binds tropomyosin, interlocking them to form the troponin-tropomyosin complex while 
troponin C binds actin and holds the troponin-tropomyosin complex in place under resting 
conditions (Yamamoto et al., 1987).  Ca2+ binding to troponin C results in a conformational 
change which causes the troponin-tropomyosin complex to shift and expose a binding site 
for myosin filaments to elicit actin-myosin cross-bridge formation (Zot et al., 1987).  
Subsequently, adenosine triphosphate (ATP) hydrolysis by myosin drives the relative 
movement of actin and myosin in process known as cross bridge cycling (Jewell, 1977; 
McDonald et al., 1994).  
Ca2+ ions function as a secondary messenger which bind to and activate calmodulin (CaM), 
a Ca2+ binding messenger protein that is ubiquitously expressed in eukaryotic cells. CaM 
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activation drives downstream cell signaling through interactions with hundreds of protein 
binding partners such as kinases or phosphatases (Chin et al., 2000). Elevated cytosolic 
Ca2+ is also known to facilitate the metabolic activity required for fertilization once the 
sperm fuses with the ovum, thus, driving the formation of new life (Slusarski et al., 2007). 
Conversely, increasing cytosolic Ca2+ levels can signal apoptosis through interactions with 
various members of the BcL-2 family in tandem with the  release of cytochrome c and 
other pro-apoptotic factors from the mitochondria (Rong et al., 2008).  
Indeed, the above examples highlight the importance and versatility of Ca2+ ions in 
physiological functions. Still, the role of Ca2+ ions also plays a critical role in maintaining 
the body’s defensive capabilities against foreign invaders (i.e. the immune system). Ca2+ 
ions play an essential role as a secondary messenger in innate and adaptive immune 
responses. In innate immunity, the increase in cytosolic Ca2+ through gap junctions at the 
site of the wounded epidermis is necessary to attract and initiate an inflammatory response 
(Razzell et al., 2013). Conversely, in long term adaptive immunity, elevated Ca2+ 
concentrations are the result of interactions between a cell surface receptor [i.e. B-cell 
receptor (BCR) for B-cells and T-cell receptor (TCR) for T-cells] binding an antigen 
provided by antigen-presenting cell (APC), thus, stimulating the activation of the B-cell 
and T-cells. The cytosolic elevation of Ca2+ concentration is regulated by the phospholipase 
C (PLC) and inositol 1,4,5-trisphosphate (IP3) signaling pathway that leads to release of 
Ca2+ from ER stores (Baba et al., 2014; Joseph et al., 2014). This release of Ca2+ from the 
ER stores signals additional Ca2+ entry into the cytosol from the extracellular space, in a 
crucial cellular process which is the focus of this thesis (see below). The activation of 
calpain, a Ca2+  dependent protease, mediates T-cell immobilization which allow T-cells to 
shape their membrane to better accommodate APCs (Selliah et al., 1996). Ultimately, given 
the vast physiological processes that require Ca2+ ions, it is evident that Ca2+ homeostasis 
is pivotal to maintaining daily bodily functions and avoiding pathologies. 
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1.1.2 The compartmentalization of Ca2+ 
To closely regulate these physiological processes, Ca2+ ions are compartmentalized in non-
continuous vesicular and continuous stores. Non-continuous vesicular stores such as 
lysosomes, and phagosomes are useful in local regulation such as membrane fusion and 
vesicular movements, while continuous stores include the intracellular organelles that can 
act as major Ca2+ storage sites such as the endo/sarcoplasmic reticulum (ER/SR) (Haller et 
al., 1996; Hilden et al., 1989; Z. Yang et al., 2015). Additionally, under basal conditions, 
the Ca2+ concentration within the mitochondria is ~0.1 nM like the cytosol. However, 
during cell stimulation, the mitochondrial Ca2+ concentration has been shown to rise to 
~100 nM – 10 mM in certain cell types (Alonso et al., 2006). Post cell stimulation, 
mitochondrial Ca2+ ions are promptly dissipated by various transmembrane Na+/Ca2+ 
antiporters and Ca2+/H+ exchangers (Palty et al., 2010). Improper Ca2+ and Na+  handling 
in mitochondria can result in heart failure which has been associated with reduced 
nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide 
phosphate (NADPH) production, ultimately leading to energetic deficits and increased 
reactive oxygen species (ROS) (Bertero et al., 2018). The Golgi apparatus has been shown 
to accumulate relatively large amounts of Ca2+ (i.e. ~ 0.3 mM) in HeLa cells which can be 
released in association with histamine-induced IP3 production (Pinton et al., 1998). Finally, 
the ER/SR are known to have largest intracellular Ca2+ store (i.e. ~ 0.4 – 0.7 mM) that can 
be released in to the cytosol, as required during specific electrical or chemical signals (H. 
E. Collins et al., 2013). The inability to regulate Ca2+ stores in the ER/SR can result in 
various diseases such as muscle disorders and immunodeficiency (Maus et al., 2015; Noury 
et al., 2017). Remarkably, the release of intracellular Ca2+ into the cytosol also induce 
extracellular Ca2+ to enter the cytosol which, in tandem, augment the cytosolic Ca2+levels 
(see below), after receiving voltage dependent or independent signals, to promptly activate 
Ca2+ dependent pathways (Putney, 1986). Furthermore, extracellular Ca2+ movement into 
the cell allows for restoration of basal Ca2 levels necessary for ER Ca2+ dependent 
processes such as protein folding and chaperone function (Braakman et al., 2013; 
Gidalevitz et al., 2013; Halperin et al., 2014).  
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1.2 Store operated Ca2+ entry (SOCE) and Ca2+ release-
activated Ca2+ (CRAC) channels 
In 1986, J.W Putney first proposed a cell signaling model for store operated Ca2+ entry 
(SOCE). Putney proposed that cell surface receptor stimulation leads to PLC-induced IP3 
production which binds to IP3 receptors (IP3R)s and leads to depletion of intracellular ER 
Ca2+ stores. Importantly, his model suggested that this ER Ca2+ depletion, activated PM 
Ca2+ channels, leading to extracellular Ca2+ entry into the cytosol (Putney, 1986). It was 
later discovered that the major players involved in SOCE were STIMs (Liou et al., 2005; 
Roos et al., 2005), which function as the ER/SR Ca2+ sensor, and the PM Ca2+ channel 
subunits known as Orai (Feske et al., 2006; Prakriya et al., 2006; Vig et al., 2006; Yeromin 
et al., 2006). The conservation of the SOCE signaling mechanism in lower order eukaryotes 
such as the common fruit fly to higher order vertebrates such as humans highlights its 
evolutionary significance in Ca2+ regulation and signaling (Cai et al. 2007).  
To induce SOCE, cell surface G-protein coupled receptor (GPCR)s bind various agonists 
such as endothelin 1 (ET-1), phenylephrine (PE) and angiotensin II (ANG II), to name a 
few, which ultimately elicits the downstream conversion of phosphatidyl inositol 4,5 – 
bisphosphate (PIP2) into IP3 mediated by PLC. IP3, acting as a secondary messenger, binds 
to IP3Rs anchored on the ER/SR membrane (Wang et al., 2005) which open and allow Ca2+ 
entry into the cytosol from the ER lumen down the steep concentration gradient. These 
initial events result in a decrease of Ca+ concentration in the ER (Korzeniowski et al., 2010; 
Muik et al., 2011; Wu et al., 2006). This drop of ER-luminal Ca2+ results in Ca2+ unbinding 
from the sensory luminal N-terminal side of STIM1 and a conformational change which 
propagates throughout the molecule (Luik et al., 2006; Zheng et al., 2008; Zheng et al., 
2011). First, dimerization and/or oligomerization of the N-terminal STIM1 domain occurs; 
second, this oligomerization promotes a compact to extended state conformational change 
on the C-terminal, cytosolic side of the protein (Muik et al., 2011); finally, the 
oligomerized/conformationally extended STIMs translocate to ER-plasma membrane 
(PM) junctions (Stefan et al., 2013). At ER-PM junctions, the polybasic domain of STIM1 
interacts with phosphoinositides of the PM and specialized cytosolic domains of STIM1 
interact with Orai1 subunits, recruiting Orai1 to the same ER-PM junctions and forming 
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Ca2+ release activated Ca2+ (CRAC) channels. STIM1 also gates CRAC channels which 
facilitate the entry of Ca2+ into the cytosol from the extracellular space. The interactions 
between STIM1 and Orai1 are necessary for forming and opening CRAC channels which 
selectively permit Ca2+ entry thereby also inducing an inward current (ICRAC) due to Ca2+ 
traversing down its concentration gradient (Stathopulos et al., 2008). 
1.3 Stromal Interaction Molecule (STIM) and Orai  
As a prominent player in myriad physiological processes, understanding the underlying 
molecular mechanisms of Ca2+ level regulation has far reaching implications. The 
existence of SOCE through CRAC channels is vital for Ca2+ signaling in both excitable as 
well as non-excitable cells. As discussed above, the ER is a major organelle involved in 
Ca2+ storage; remarkably, this organelle also has proteins which regulate Ca2+ entry in other 
parts of the cell. Embedded on the ER membrane is STIM1, a type I transmembrane protein 
which interacts with Orai, on the PM, to form CRAC channels (Cahalan, 2009). STIMs 
function as finely tuned ER/SR Ca2+ sensors and CRAC channel activators (Liou et al., 
2005; Zhang et al., 2005), whilst Orai subunits make up the CRAC channels which 
facilitate Ca2+ entry from the extracellular space into the cytosol (Cahalan, 2009; Gudlur 
et al., 2013; Ji et al., 2008; Penna et al., 2008; Soboloff et al., 2006). Interestingly, STIM1 
and Orai1 were shown to play an apoptotic role in pancreatic adenocarcinoma cell lines 
which was further exuberated with chemotherapeutic drugs such as 5-fluorouracil or 
gemcitabine shown to induce SOCE. However, siRNA-mediated knockdown of STIM1 or 
Orai1 resulted in a marked reduction in apoptosis when used with either chemotherapeutic 
agent. This suggests a novel form of chemotherapeutic treatment for pancreatic cancer cells 
through a calcium-dependent mechanism of action (Kondratska et al., 2014).  
In knockout mice lacking Orai1, SOCE was impaired in naïve CD4+ and CD8+ T-cells 
whereas in vitro differentiated cells exhibited nearly complete abolishment of SOCE and 
CRAC functionality resulting in compromised immune function (Shaw et al., 2012). 
Similarly, lymphocytes extracted from patients with primary immunodeficiencies had 
exhibited defective ICRAC, and thus, a loss of CRAC functionality (Le Deist et al., 1995; 
Partiseti et al., 1994). Furthermore, heritable mutations in Orai1 (e.g. R91W) have been 
identified in severe combined immunodeficiency (SCID) human patients where there was 
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loss of CRAC functionality coupled with the reduction in cytokine production (Feske et 
al., 2006). Taken together, these studies using cell lines, animal models and primary cells 
obtained from humans with genetic defects in SOCE have emphasized the importance 
STIM and Orai proteins in regulating SOCE function and CRAC channel activity in health 
and disease (Penna et al., 2008). 
1.3.1 STIM domain organization 
STIMs are essential Ca2+ sensors and activators of SOCE that are expressed ubiquitously 
throughout most eukaryotic cells. These Ca2+ sensors are required to maintain normal 
human physiology and drive pathophysiological alterations (Bergmeier et al., 2013; Cui et 
al., 2017; Soboloff et al., 2012). There are two human homologues that share high 
similarity in amino acid sequence and domain architecture, STIM1 (685 residues; NCBI 
Accession: NP_003147.2) and STIM2 (746 residues; NCBI Accession: NP_065911.3) 
(Hooper et al., 2013). As human STIM1 is a type I TM protein, it consists of two distinct 
regions which are separated by a single TM and where region each plays a vital role in 
SOCE activation and Ca2+ regulation. In addition to a role in SOCE, STIM2 has a major 
role in mediating basal Ca2+ homeostasis (Brandman et al., 2007). Unlike STIM1, a fraction 
of STIM2 is active when the ER Ca2+ stores are full which is probably attributed to the 
weaker Ca2+ binding affinity of STIM2 further discussed below (Brandman et al., 2007; 
Stathopulos et al., 2013; Zhou et al., 2009). 
In the luminal N-terminal region of STIM1 downstream of the ER signaling peptide (i.e. 
residues 1 – 22), there are two conserved cysteine residues (Cys49 and Cys56), the 
canonical EF-hand (i.e. residues 63 – 96), non-canonical EF-hand (i.e.  residues 97 – 128) 
motifs, and sterile α motif (SAM) (Hooper et al.) (i.e. residues 132 – 200) which 
collectively mediate the Ca2+ sensing function of STIMs (i.e. EF-SAM). According to the 
three-dimensional structure of STIM1 EF-SAM, the non-canonical EF hand and SAM 
region are connected through a linker region. Furthermore, this non-canonical EF-hand 
also forms hydrogen (H)-bonds with the canonical EF-hand and together the EF-hands 
form a pocket for SAM domain interactions in the presence of Ca2+. In the depleted state, 
the canonical EF-hand loses the Ca2+, STIM1 undergoes destabilization followed by 
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dimerization/oligomerization which initiates the SOCE process (Stathopulos et al., 2010; 
Stathopulos et al., 2009; Stathopulos et al., 2008). 
Fluorescence resonance energy transfer (FRET) and total internal reflective fluorescence 
(TIRF) have demonstrated that the oligomerization and translocation of STIM1 in response 
to luminal Ca2+- depletion, causes distinct STIM1 punctate aggregates to form at ER-PM 
junctions (Liou et al., 2005; Stathopulos et al., 2009). Furthermore, substitution of the 
STIM1 EF-SAM region with FK506-binding protein, a rapamycin-binding protein and the 
addition of rapamycin, induce oligomerization and translocation of the STIM1 chimera 
(Luik et al., 2008). Conversely, complete removal of SAM prevents puncta formation at 
ER-PM junctions (Baba et al., 2006). These findings highlight how essential 
oligomerization of the N-terminal domain is for translocation of STIM1 to ER-PM 
junctions and activation of CRAC channels.  
After the single-pass TM, the cytosolic C-terminal region of STIM1 contains three coiled-
coils (i.e. CC1-CC2-CC3) that each play different roles in mediating SOCE (Stathopulos 
et al., 2013). CC1 (i.e. residues 238-337), the first and longest of the three conserved 
domains, has an -helical structure spanning approximately 13 nm in length (Cui et al., 
2013). CC1 does not contain any of the machinery required for physically coupling to and 
opening of CRAC channels; however, after the transition of the cytosolic C-terminal 
domains to the extended conformation, the CC1 length allow STIMs to bridge the distance 
between the ER and the PM and physically couple with Orai1 channel subunits on the 
opposite membrane (Calloway et al., 2011). CC2 (i.e. residues 363-389) together with CC3 
(i.e. residues 399 – 423) make up the minimal boundaries within CC domains necessary 
for coupling to and opening CRAC channels. This region is known as the CRAC activating 
domain (CAD) (Park et al., 2009), STIM-Orai activating region (SOAR) (i.e. residues 344 
– 442) (Yuan et al., 2009), or cc boundary 9 (Kawasaki et al., 2009) defined by the residues  
342 – 448, 344 – 442 and  339 – 446,  respectively, by three independent studies. Together, 
the three coiled-coil domains fall within the Orai-activating STIM fragment (OASF) (i.e. 
residues 234-491) which are critical for mediating the compact to extended conformation 
of the molecule as well as coupling to and activation of Orai channels, and thus, SOCE 
(Fahrner et al., 2009). Mutations that occur along these CC regions can lead to pathological 
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diseases in humans via either persistent activation or abolishment of SOCE (Maus et al., 
2015; Miederer et al., 2015). 
Further downstream of CC1-CC2-CC3 is an acidic inhibitory domain (ID) (i.e. residues 
470 – 491) that is involved in the Ca2+ dependent inactivation of STIM1, after the activation 
SOCE (Derler et al., 2009a). A Pro/Ser-rich region (i.e. residues 600 – 629) has several Ser 
residues that undergo phosphorylation and a polybasic (i.e. Lys-rich) region (i.e. residues 
671 – 685) that directly interacts with PM phosphoinositides, as deleting this region 
disrupts STIM’s ability to interact with the PM (Stathopulos et al., 2013). Ultimately, the 
EF-SAM, CC regions, Pro/Ser and polybasic regions collectively enable STIM1 to undergo 
the multi-step process required to couple with Orai1, activate SOCE and confer a complex 
molecular regulation which is not fully understood.  
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Figure 1.3. Multiple amino acid sequence alignment of STIMs from lower to higher 
order organisms. Homo sapiens STIM1 (Accession: AFZ76986.1), H. sapiens STIM2 
(Accession:NP_065911.3), H. sapiens STIM2 (Accession: NP_001162589.1), Mus 
musculus STIM1 (Accession: NP_033313.2), M. musculus STIM2 
(Accession:NP_001074572.2), M. musculus STIM2β (Uniprot:F6WBP9), Drosophila 
melanogaster STIM (Accession:NP_523357.2), Gallus gallus STIM 
(Accession:NP_001026009.1), Caenorhabditis elegans STIM 
(Accession:NP_001022916.1). Residues that are fully conserved, highly conversed, and 
partially conversed are indicated with (*), (:) and (.), respectively, under the alignment. 
Residues colour code in accordance to amino acid properties: acidic (blue), basic (pink), 
polar uncharged (green) and hydrophobic (red). Sequence alignment was performed using 
Clustal Omega. Each domain is shaded as per Figure 1.2. 
  
14 
 
1.3.2 Orai organization  
Orai1 is the subunit component that, when recruited by STIM1, assembles into Ca2+-
selective CRAC channels which mediate SOCE and cytosolic Ca2+ flux. The high-
resolution structure of the human Orai homologue assembly has remained elusive. 
Fortunately, previous studies, through X-ray crystallography, have resolved an Orai 
homologue crystal structure of D. melanogaster sharing high sequence similarity (> 70%) 
with human Orai1 within the transmembrane (TM) region (Cai, 2007). The crystal structure 
has shown that a single Orai channel exhibits a hexameric quaternary structure (Hou et al., 
2012; Ji et al., 2008; Maruyama et al., 2009; Penna et al., 2008). Sequence analysis and the 
structure has shown that Orai is composed of four major TM helices (i.e. M1-M4). These 
four TM helices are arranged in concentric rings whereby the innermost core consists of 
M1 from each of the six subunits (Hou et al., 2012). M2 and M3 immediately surround 
M1, with the M1 helix extending through the lipid bilayer into the cytosol. The M2 and 
M3 arrangement in surrounding M1 implies a role in promoting subunit structural integrity. 
Finally, the M4 helix, forming the outermost layer, extends into the cytosol and is kinked 
so that a C-terminal extension runs parallel to the plane of the inner PM leaflet. The 
extended C-terminal part of M4 interacts antiparallelly with a neighboring extended M4 
helix, which also adopts a kink which extends in the opposite direction. Ultimately, the 
gross structure of Orai shows the innermost pore exhibiting a six-fold symmetry, while the 
peripheral region exhibits a threefold symmetry due to pairwise M4 coiled-coil interactions 
(Enomoto et al., 2017).  
Both the N- and C-termini of Orai face the cytosol and interact with the CAD domain of 
STIM1. The Orai N- and C-termini interactions with the CAD domain are involved in 
recruitment of the channel subunit and gating of the pore (Frischauf et al., 2009; Muik et 
al., 2009; Stathopulos et al., 2013). There are three Orai human homologues: Orai1, Orai2, 
and Orai3. All Orai homologues contain highly conserved TM regions (i.e. M1-M4) and 
linker regions as well as acidic and basic residues required for Ca2+-selectivity and 
permeability. All three Orai homologues can be activated by STIM1 and exhibit varying 
biophysical properties depending on the STIM1:Orai combination in specific cell types 
(Frischauf et al., 2009). Interestingly, a missense mutation (i.e. R91W) in human Orai1 
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resulting in a loss of Ca2+ entry via CRAC channels causes a heritable form of SCID (Derler 
et al., 2009).  
1.3.3 Modifications to STIM 
SOCE activation is a methodical multi-step process culminating in STIM1:Orai1 coupling. 
As highlighted previously, STIM1 is the major Ca2+ sensor in the ER/SR which ultimately 
gates CRAC channels and facilitates Ca2+ entry into the cytosol. Through the EF-SAM 
domain, STIM1 senses changes in luminal Ca2+ concentration via Ca2+ binding or release 
while the OASF region with the three CC domains controls the conformational extension 
on the cytosolic side of the molecule and directly interacts with Orai subunits embedded in 
the PM (Stathopulos et al., 2013).  
When Ca2+ levels in the ER/SR lumen are high, Ca2+ is bound to the EF-SAM domain of 
STIM1 keeping it in a dormant, inactive state. The drop of Ca2+ concentration mediated by 
IP3R channels, results in a loss of Ca2+ from EF-SAM leading to a conformational change 
which propagates throughout the molecule. First, dimerization and/or oligomerization of 
the N-terminal domain occurs; second, this oligomerization promotes a transition within 
the CC region of the cytosolic side of the molecule from a compact to extended state  (Muik 
et al., 2011); finally, the oligomerized/conformationally extended molecule translocates to 
the ER-PM junctions. At ER-PM junctions, STIM1 recruits Orai1 subunits to form the 
CRAC channel complex (Stathopulos et al., 2013). Active CRAC channels can also be 
deactivated by the previously mentioned ID region downstream of CC3 (i.e. 470 – 491) 
within STIM1 in a process known as Ca2+ dependent inactivation (CDI) (Derler et al., 2009; 
Mullins et al., 2009; Roos et al., 2005; Soboloff et al., 2006). Additionally, CaM has been 
found to inhibit SOCE via interaction with the polybasic domains of STIM1 and STIM2, 
preventing translocation to ER-PM junctions (Bauer et al., 2008; Calloway et al., 2011; 
Singh et al., 2002; Walsh et al., 2009; Yuan et al., 2009). 
The luminal domain destabilization and subsequent conformational extension of STIM1 in 
response to ER/SR luminal Ca2+ depletion are integral steps in SOCE. Thus, in-depth 
studies have investigated the modifications that affect STIM1 stability revealing important 
mechanistic insights into STIM1 activation. Within the luminal domain of STIM1 are 
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modifiable residues that modulate the stability of EF-SAM, and thus, the activation of 
SOCE (Gui et al., 2018; Stathopulos et al., 2009; Zhu et al., 2018). The S-nitrosylation of 
Cys49 and Cys56 in STIM1 increased thermodynamic stability of the luminal domain 
which resulted in suppressed hydrophobic exposure and a loss of Ca2+ depletion-dependent 
oligomerization (Zhu et al., 2018). Furthermore, N-glycosylation of Asn131 and Asn171 
sites lead to the decreased Ca2+ binding affinity, reduced stability and enhanced 
oligomerization in response to ER Ca2+-depletion. In human embryonic kidney (HEK) 293 
cells co-expressing Orai1 and STIM1,  blocking Asn131 and Asn171 N-glycosylation sites 
diminishes SOCE, suggesting these sites enhance the EF-SAM destabilization-coupled 
oligomerization in response to ER Ca2+-depletion (Choi et al., 2017). These results show 
that these modifiable sites on the EF-SAM domain act as robust ON/OFF regulators of 
SOCE.  
Modifications in the STIM CC regions can lead to a loss of Ca2+ homeostasis which give 
rise to various pathologies such as Stormorken Syndrome (i.e. R304W) which is the result 
of SOCE upregulation (Misceo et al., 2014; Morin et al., 2014; Noury et al., 2017) or SCID-
like syndrome (i.e. R429C) due a reduction in SOCE activity (Maus et al., 2015). Still, 
modifications in the CC region can also act as a regulatory means for cells to control SOCE. 
One such example occurs through the phosphorylation of residue T389 that results in a 
selective inhibition of STIM and activation of store-independent arachidonic acid–
activated (ARC) channels. ARC channels function differently from CRAC channel in that 
they activate independent of Ca2+ store depletion and are comprised of both Orai1 and 
Orai3 subunits (Thompson et al., 2015; Thompson et al., 2018). Recently, it was discovered 
that alterative splicing is a viable means of SOCE regulation; an 8-amino acid residue (i.e. 
referred to as the 2insert in this thesis) spliced into exon 9 generates a STIM2 variant that 
can also inhibit SOCE (Miederer et al., 2015; Rana et al., 2015). Both phosphorylation and 
alterative splicing are fascinating features that enable cells to regulate SOCE. Alternative 
splicing and the R304W and R429C mutations are discussed in more detail below. 
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1.4 STIM2 is a basal modular of SOCE  
While STIM1 is a prominent activator of SOCE through dynamically changing its 
conformation and gating CRAC channels, STIM2 plays an important role in maintaining 
the basal luminal and cytosolic Ca2+ concentration, also by interacting with Orai1-
composed channels. The importance of tight control of basal Ca2+ concentration is 
emphasized by the various diseases that are associated to prolonged increased or decreased 
basal Ca2+ concentration (Brandman et al., 2007). Diseases associated with basal Ca2+ 
imbalance include endothelial dysfunction, kidney disease, cardiac dysfunction and 
neurodegenerative diseases such as Huntingtons and Alzheimers diseases (Schulman et al., 
2005; Ter Keurs et al., 2007; Thebault et al., 2006). Indeed, a genetic inheritable mutation 
found in presenilin from Alzheimer patients is associated with defects in Ca2+ homeostasis 
due to changes in Ca2+ flux out of ER Ca2+ stores (Tu et al., 2006). Basal Ca2+ imbalance 
also associated with altered protein degradation and transcription that can affect 
intracellular signaling and thus the overall cell health (Berridge et al., 2003; Spira et al., 
2001). In T-cells and fibroblasts, STIM2 is highly upregulated after stimulation of T-cells 
and allows for prolonged long-term Ca2+ signaling allowing ER Ca2+ levels to remain high 
which prevents an ER stress response whilst driving long term SOCE influx (Collins et al., 
2011; Oh-Hora et al., 2008). 
STIM2 can induce Ca2+ influx by interacting with Orai1 in a store-dependent or store-
independent manner though its mechanism of activation which remains incompletely 
understood.  One distinguishing factor between the STIM homologues is the EF-SAM Ca2+ 
sensitivity. Based on ER Ca2+ concentration estimates required for puncta formation, the 
STIM1 dissociation equilibrium constant (Kd) is ~200 μM whereas STIM2 exhibits a 
relative functional Kd of ~400 μM Ca2+ (Brandman et al., 2007). These data are in-line with 
previous Kd measurements of EF-SAM which suggest STIM2 has a relatively weaker Ca2+ 
affinity compared to STIM1 EF-SAM (Brandman et al., 2007; Stathopulos et al., 2009; 
Zheng et al., 2008). Thus, STIM2 becomes Ca2+ depleted at higher ER luminal Ca2+ levels 
compared to STIM1. Interestingly, in cells where both proteins are present, the difference 
in STIM2 Ca2+ affinity implies that it is more suited as a feedback modulator to keep basal 
Ca2+ cytosolic and ER Ca2+ within a tight range. This idea is supported given that knocking 
18 
 
down STIM2 in HeLa, HUVEC and HEK293 cells selectively lowered overall basal 
cytosolic and ER Ca2+ concentrations whereas knocking down STIM1 in the same cell 
types had a less pronounced effect on basal Ca2+ levels (Brandman et al., 2007). 
Furthermore, STIM2 is present at lower levels relative to STIM1 in most human tissues, 
exhibits lower relative activity and responds to smaller changes in Ca2+ concentration when 
expressed and measured in HEK293 cells (Parvez et al., 2008).  
While the majority of STIM2 is localized on the ER membrane, a secondary functional 
form of STIM2, pre-STIM2, may accumulate as a full-length pre-protein in the cytosol. 
Pre-STIM2 is found embedded in the inner leaflet of the PM and in the cytosol where it 
can interact with Orai1 to regulate basal Ca2+ concentrations and Ca2+ dependent gene 
transcription in an ER Ca2+-independent manner (Graham et al., 2011). 
1.5 Mutating the CC regions alter SOCE functionality  
The cytosolic CC regions facilitate direct STIM interactions with PM Orai subunits. 
Modifications in the CC region can lead to a drastic change in Ca2+ homeostasis as the 
ability of STIM to interact with Orai can be become constitutive or severely hindered. One 
major type of modification are missense point mutations. Missense mutations are points 
mutations where a single nucleotide is altered such that the codon is translated into a 
completely different amino acid. In STIM, changing specific amino acids due to missense 
mutations on the CC region have been shown to alter SOCE activity.  
The Arg309Trp (R304W) mutation gives rise to an autosomal dominant disorder known as 
Stormorken Syndrome characterized by phenotype that includes profuse bleeding due to 
thrombocytopenia, aggregate tubular myopathy and miosis (Noury et al., 2017). 
Stormorken syndrome patients experience a gain-of-function where their STIM1 exhibits 
hyper-activation independent of luminal Ca2+ levels leading to upregulated SOCE. R304 
of STIM1 is localized within the CC1 domain and is thought to form a salt bridge with 
E318 while simultaneously forming a hydrogen bond with the main oxygen atom of Q314 
within this coiled-coil. By substituting in tryptophan, the salt bridge and hydrogen cannot 
be formed which effectively prevents the inhibitory helix from keeping the CAD domain 
19 
 
of STIM1 in its dormant state when ER Ca2+ levels are replete (Fahrner et al., 2018; Morin 
et al., 2014; Shen et al., 2012; Yang et al., 2012).  
Conversely, Arg429Cys (R429C) has been associated with severe combined 
immunodeficiency (SCID)-like syndrome which is characterized by the inability to activate 
CD4+ and CD8+ in response to acute viral infections. This inability to activate immune 
cells is attributed to the severe abolishment of SOCE. R429 is localized on CC3 of the 
STIM1 cytosolic domains, and the substitution from Arg to Cys destabilizes the CC3. 
Interestingly, the mutation impairs cytoplasmic STIM1 oligomerization which abolishes 
STIM1-Orai1 interactions in fibroblast and T-cells despite being able to localize to the ER-
PM junctions (Maus et al., 2015). Given that STIM1 cannot recruit Orai1 to form functional 
CRAC channels, SOCE is abolished which hinders the immune response.  
1.6 Alterative splicing of STIM2 
Alterative splicing is a regulated process that occurs in eukaryotes in which a single gene 
can code for multiple protein isoforms. Unlike mutations that occur at the nucleotide level 
resulting in gain or loss of functions, alterative splicing occurs during post transcriptional 
modifications, generating a new type of protein. During post transcriptional modification, 
exons from a gene can be spliced in or out of the processed messenger RNA (mRNA). 
Consequently, the proteins translated from the alternatively spliced mRNAs will have 
varying amino acid sequences and thus, also have varying biological functions. What 
makes alterative splicing so vital is that it has allowed the human genome to synthesize 
more proteins than would otherwise be possible from the ~20,000 genes, thereby 
expanding the human proteome (Graveley, 2001; Kim et al., 2014).  
Alterative splicing can determine the intracellular localization, protein stability, and 
binding properties of many proteins. In intracellular localization, alterative splicing can 
influence localization of protein in various subcellular sites and organelles. Often, this 
mechanism is used for receptor molecules to regulate their retention in membrane-enclosed 
compartments. For example, a dopamine D2 receptor splice variant is retained more 
efficiently in the ER compared to other dopamine isoforms which reduces the overall 
dopamine D2 activity (Chan et al., 2001). By including alterative protein domains, the 
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overall half-life of protein can be regulated. An alternative form of human thyroperoxidase, 
an enzyme expressed in the thyroid which oxidizes iodine atoms, exhibits a reduced half-
life and is very abundant in Grave’s disease (Niccoli-Sire et al., 2001). Additionally, the 
effect of alterative splicing can alter the binding affinity of a protein (Kelemen et al., 2013). 
Generally, isoforms that exhibit a complete loss in ligand binding have a dominant-
negative effect over isoforms still able to bind biological ligands (Kelemen et al., 2013). 
Alternative splicing of thyroid stimulating hormone (TSH) receptors (TSHR) generates a 
variant that is unable to bind TSH. These TSHR variants are often linked with TSH-
secreting tumors and yield severe insensitivity to TSH (Ando et al., 2001). Alterative 
splicing can also affect the ligand specificity of a receptor such as in fibroblast growth 
factor receptor gene (FGLR)-2 that generates two isoforms differing by 49 amino acids on 
the extracellular domain. Whether or not the domain is present, dictates if the receptor 
binds both the fibroblast and keratinocyte growth factors or just the fibroblast growth factor 
(Miki et al., 1992).  
1.7 STIM splice variants 
STIM1 and STIM2 can be regulated at the transcriptional level through alterative splicing, 
generating novel isoforms from a single STIM1 or STIM2 gene. STIM1L is a longer splice 
variant generated by alterative splicing of the STIM1 gene and is expressed in human and 
mouse skeletal muscles (Horinouchi et al., 2012). STIM1L was initially thought to play a 
role in the quick activation of SOCE to induce sustained ER Ca2+ store refilling during 
intensive muscle stimulation since it was shown to be pre-clustered (Darbellay et al., 2011). 
Contrary to this view, it was found that STIM1L can recruit and activate PM Orai1 channels 
in a store-dependent manner without remodeling the ER cisternae as seen for STIM1. The 
ability to remodel the ER cisternae during SOCE activation is attributed to the polybasic 
C-terminal region (i.e. residues 671 – 685) involved in STIM1 binding to 
phosphoinositides. Despite STIM1L having the same lysine-rich region, the inability to 
expand the ER cisternae suggest that STIM1L does not mediate rapid SOCE like STIM1 
but can trap and gate Orai1 subunits without remodeling the ER cisternae (Sauc et al., 
2015). Previous studies have shown that STIM1L can also interact with transient receptor 
potential canonical (TRPC) channels, which are all activated downstream of the IP3 
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pathway. TRPC channels are non-selective channels with some preference for mediating 
Ca2+ flux (Horinouchi et al., 2012). TRP channels are effectors of a variety of external 
sensations such as temperature, taste, pressure and vision (Brauchi et al., 2006; Levine et 
al., 2007; Vriens et al., 2014). STIM1L appears to be a specialized molecule which forms 
a pre-existing site of contact compared to the more versatile STIM1 capable of remodeling 
the ER during Ca2+ signaling.  
Through the retaining of exon 9, STIM2 can be alternatively spliced into the STIM2 
isoform. STIM2has an extra 8-residue insertion (VAASYLIQ) near the end of CC2 
called the 2 insert that is absent in other isoforms of STIM and is the first STIM isoform 
shown to inhibit SOCE (Miederer et al., 2015; Rana et al., 2015). An amino acid sequence 
comparison across higher to lower order species (i.e. C. elegans to H. Sapiens) show that 
this 2 insert is present only in vertebrates (Figure 1.2). Inducing mutations along the 2 
insert reduces the inhibitory activity of STIM2 (Rana et al., 2015), implying the 
conservation of the 2 insert sequence is critical for STIM2 to exert its inhibitory effects. 
Inclusion of this insert prevents STIM2 from recruiting Orai1 in response in Ca2+ 
depletion. Expression of STIM2 in HEK293 cells shows that STIM2 cannot activate 
Orai1 channels. Further, the mechanism by which STIM2 can exert an inhibition on 
SOCE even in the presence of other co-expressed STIM isoforms without interacting with 
Orai1 remains unclear. When STIM2 is heterodimerized with STIM1, it can be localized 
to ER-PM junctions and interact with Orai1 subunits (Rana et al., 2015). Thus, it is possible 
the STIM1:STIM2 heteromeric interaction could play a role in the inhibitory activity of 
STIM2. Ultimately, alterative splicing is a form of largely unexplored SOCE regulation 
serving to balance and regulate activation and inhibition.  
1.8 Rationale  
The STIM-Orai system is central to Ca2+ signaling processes in health and disease. STIM1 
is a major activator of SOCE and contains two distinctly functioning regions. The luminal 
domain region is responsible for Ca2+ sensing while the cytosolic domain region enables 
the oligomerization, translocation as well as interactions with Orai1. Thus, the cytosolic 
domains contain the machinery essential for CRAC channel activation. Although the 
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functions that the various STIM1 domains play in activating SOCE have been identified, 
the precise effects of the 2 insert on the molecular mechanisms of SOCE regulation 
remains poorly understood. Given that mutations within the CC region of STIM1 
profoundly change the biophysical properties of STIM1 which affect interactions with 
Orai1 activity (Maus et al., 2015; Morin et al., 2014; Thompson & Shuttleworth, 2015), I 
predict that the 2 insert will also dramatically affect the CC region biophysical properties 
critical to the function of the molecule. 
Some of these mutations directly hinder STIM1:Orai1 coupling after normal Ca2+-sensing, 
oligomerization, conformational extension and interactions with the PM (i.e. R429C). 
Similarly, the STIM2 isoform does not appear to couple with Orai1. Thus, the 2 insert 
in the CC region of STIM2 may alter the structural conformation of OASF which prevents 
STIM2 localizing to the ER-PM junctions and gating of the Orai-composed Ca2+ 
channels. Remarkably, however, despite the inability to directly bind Orai, STIM2 can 
still elicit an inhibitory action on SOCE, which is why I hypothesize that alterative splicing 
at the transcriptional level of STIM2 has an important regulatory role. This inhibition 
mechanism of STIM2 remains poorly understood and represents a major knowledge gap 
in the field. Given that STIM2 is known to be basal modulator of luminal and cytosolic 
Ca2+, STIM2 likely also plays a role in basal Ca2+ regulation. 
1.9 Hypothesis and Research Aims 
Hypothesis: I hypothesize that the 2 insert (VAASYLIQ) within the OASF STIM1234-
491 and STIM2325-583 (subscripted numbers represent the residue range) will perturb the CC 
conformation, structure, stability and dynamics commensurate with the ability to activate 
SOCE. 
Aim 1: To introduce STIM1 and STIM2 2 insert (VAASYLIQ) mutations into pET-28a 
recombinant STIM1234-491 and STIM2325-583 expression vectors and isolate high levels of 
homogeneous OASF proteins for subsequent structural and biophysical analyses.  
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Aim 2: To investigate the effects of the 2 insertion on the i) structure, ii) association 
propensity and iii) Ca2+ sensitivity of STIM1 and STIM2 OASF, and to probe how 
structural and biophysical perturbations caused by the 2 insert alter the mechanisms of 
full-length STIM-mediated SOCE. Since high-resolution structures of the STIM1 CC 
region, but not STIM2, are available, and given the high sequence conservation between 
the STIM1 and STIM2 CCs (i.e. >70% sequence similarity) (Zheng et al., 2008), we will 
use STIM1 as a helpful surrogate to study the structural, biophysical and biochemical 
effects of the 2 insert. Considering the high sequence conservation of the CC region 
among all STIM homologues and isoforms (Figure 1.2), understanding the structural, 
biophysical, and biochemical consequences of 2 insert incorporated into both STIM1 and 
STIM2 OASF will reveal insights into the molecular mechanisms of STIM function as well 
as the factors which contribute to dysfunctional SOCE and disease.  
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2 Chapter 2: Methods 
2.1  Generation of the STIM2 OASF pET-28a 
recombinant vector  
In order to assess the biophysical effects of the 2 insert on STIM conformation, the OASF 
of STIM2 (residues 325-583; NCBI Accession: NP_065911.3) was first cloned into a pET-
28a expression vector that was previously successful in the expression of the OASF region 
of human STIM1 (Muik et al., 2011). The generation of the STIM1-OASF (residues 234-
491; NCBI Accession: NP_003147.2) pET-28a vector was completed in a previous study 
(Muik et al., 2011) and was used again in my study to assess the biophysical effects of 2 
insert on STIM1 OASF.  
The H. sapiens STIM2 OASF region was subcloned from a pCMV6-STIM2 (residues 1-
746) template into a pET-28a recombinant vector using NheI and XhoI restriction sites. A 
100 µL PCR solution mixture containing the NheI and XhoI restriction sites at the 5’ and 
3’ ends, respectively, was prepared using 75 µL dH2O, 20 µL 5× high fidelity (HF) buffer 
(Thermo Fisher Scientific), ~30 ng of pCMV6-STIM2 template, ~500 ng forward, ~500 
ng reverse primer, 2.0 µL of 10 mM dNTPs and 1.0 µL Phusion DNA polymerase (Thermo 
Fisher Scientific). The PCR mixture was amplified in a thermal cycler (Eppendorf® 
Mastercycler) using the parameters detailed in Table 2.2.  
The final PCR product was electrophoresed at 125 V for 50 min on a 1.5 % (w/v) agarose 
gel submerged in 0.5× TRIS, acetic acid and ethylene diamine tetra acetic acid (TAE) 
buffer. Moreover, to assess the band size of the PCR product, 2 µL of DNA ladder 
(GeneRuler 1kb Plus, Thermo Fisher Scientific) was loaded into a separate lane. The 
agarose gel was submerged in 0.5 µg mL-1 ethidium bromide (EtBr) solution and allowed 
to shake at room temperature for 30 min. The gel was subsequently visualized under UV 
light (302 nm). The STIM2 OASF DNA insert encoding residues 325-583 and 
corresponding to ~774 basepairs (bp) was excised and transferred into a separate 
Eppendorf® tube. The DNA was extracted from the gel using GeneFlow Gel/PCR 
purification kit according to the manufacturer’s protocol.  
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NheI and XhoI double digestions of the insert and target vector (i.e. pET-28a) were 
separately performed to generate compatible sticky end overhangs. The digestion mixtures 
were prepared in two individual Eppendorf® tubes. The first tube contained 35 µL of the 
STIM2 OASF insert (i.e. STIM2325-583), 4.1 µL CutSmart buffer and 0.5 µL of each 
restriction enzyme (NheI and XhoI restriction enzymes). The second tube contained 7.5 
µL pET-28a vector (~1 g DNA), 2 µL CutSmart buffer, 1 µL of each restriction enzyme 
and 8.5 µL dH2O. Both digestion mixtures were incubated overnight at 37 °C. The digested 
DNA samples were subsequently separated on an 1.5% (w/v) agarose gel, stained with 0.5 
µg mL-1 EtBr and visualized under UV light. The digested DNA bands containing the 
STIM2325-583 insert and pET-28a vector with compatible sticky ends were extracted from 
excised gel fragments using the GeneFlow Gel/PCR kits.    
The digested STIM2 OASF insert was ligated into the pET-28a recombinant vector by 
combining 4.5 µL dH2O, 3.0 µL of the digested pET-28a vector, 10 µL of digested STIM2, 
OASF insert and 2 µL of 2× T4 DNA ligation buffer (New England Biolabs) into an 
Eppendorf tube. The mixture was heated at 42 °C for 2 min, subsequently chilled on ice 
for 1 min and supplemented with 1 µL of T4 DNA ligase (New England Biolabs). The 
ligation mixture was incubated in a water bath at 16 °C for ~16 h. Subsequently, the ligated 
DNA was transformed into DH5α E. coli by mixing 7.5 µL of the ligation product with 
100 L cells. The cells were incubated on ice for 60 min and subsequently heat shocked at 
42 °C for 45 s. The heat shocked cells were subsequently transferred into 900 L of Luria-
Bertani (LB) broth contained within a 15 mL Falcon tube. The Falcon tube was incubated 
at 37 °C with constant shaking at 200 rpm. After 90 min, the LB broth was transferred into 
an Eppendorf tube and centrifuged at 10,000 ×g for 10 min. The resulting cell pellet was 
resuspended in ~100 L LB and plated on an agar plate containing 60 µg mL-1 kanamycin. 
The plate was incubated overnight in a 37 °C air incubator.  
The resultant colonies were screened for the presence of the pET-28a vector containing the 
STIM2325-583 insertion by PCR. Colonies were individually suspended in 20 µL of dH2O. 
5 µL of this “colony solution” was added to 10 µL of 2× Taq Frogga Master Mix 
(Froggabio), ~250 ng T7 forward primer, ~250 ng T78 reverse primer and 4 µL dH2O. The 
mixture was subjected to 25 cycles of PCR as detailed in Table 2.2. The mixture was 
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subsequently separated by gel electrophoresis on a 1.5% (w/v) agarose gel at 125 V for 50 
min and stained in 0.5 µg mL-1 EtBr. Colonies that yielded the expected band size assessed 
using the PCR screening approach (i.e. ~900 bp) were subsequently grown in 5 mL of LB 
broth containing 60 µg mL-1 of kanamycin overnight at 37 °C with constant shaking at 200 
rpm. The following day, the pET-28a plasmids with the STIM2325-583 insertion were 
isolated from the 5 mL liquid culture using the Presto Mini Plasmid Kit (Geneaid) in 
accordance to the manufacturer protocol. The isolated pET-28a-STIM2-OASF vectors 
were confirmed to contain the STIM2325-583 OASF insertion in the correct reading frame 
by DNA sequencing (Robarts DNA Sequencing Facility, London, ON). 
2.1.1 PCR mutagenesis for incorporation of the 2β insert into the 
STIM1 and STIM2 OASF pET-28a recombinant vectors 
To facilitate the 2 insert into H. sapiens STIM1-OASF and H. sapiens STIM2-OASF, a 
global sequence alignment using Clustal Omega was performed comparing the position of 
2 insert on STIM2 and its absence in the other STIM homologues. Two sets of 
complementary primers were designed after the correct residues positions were determined 
at the nucleotide level for both STIM1-OASF and STIM2-OASF. The primers were 
synthesized by Sigma-Aldrich using a 0.025 µmol scale and cartridge purification (see 
Table 2.1).   
PCR-mediated mutagenesis was used to incorporate the 2 insertions into the pET-28a 
STIM1- and STIM2-OASF vectors. A 20 µL PCR solution mixture was created using 13.8 
µL dH2O, 4 µL 5× HF buffer (Thermo Fisher Scientific), ~75 ng of the vector template, 
~125 ng forward or reverse primer, 1.0 µL DMSO, 0.5 µL of 10 mM dNTPs and 0.5 µL 
Phusion DNA polymerase (Thermo Fisher Scientific). At this stage, each primer was kept 
in a separate PCR tube (i.e. one reaction with the forward and one reaction with the reverse 
primer). The two PCR mixtures for each of the STIM1 and STIM2 OASF vectors were 
placed into a LifeECO thermocycler (BioER) and subjected to an initial 10 cycles of PCR 
as detailed in Table 2.2. After the 10 cycles, the two mixtures were pooled together for a 
total volume of 50 µL and subjected to another 25 cycles with the parameters highlighted 
in Table 2.2.  
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As a first check of whether the mutagenesis was successful, a 1.5 % (w/v) agarose DNA 
gel was used to confirm the PCR amplification of the vectors. A 15 µL aliquot was taken 
from the mixture and loaded onto a 1.5 % (w/v) agarose gel along with an equal amount of 
unamplified of vector template acting as a control and 2 µL DNA ladder (GeneRuler 1kb 
Plus, ThermoFisher) to assess the PCR product size. Upon confirmation of vector 
amplification via increased band intensity over vector control amount, 0.3 µL DpnI (New 
England BioLabs) was added to the remaining 25 µL of PCR product and incubated for 2 
h 30 min at 37 °C in an air incubator to digest the methylated template plasmid DNA.  
The PCR-amplified, unmethylated mutant plasmid was subsequently transformed into 
DH5 E. coli as described in Section 2.1.1. The following day, resultant colonies were 
selected and transferred into 5 mL of LB for overnight culture. The following day, a mini-
prep using the Presto Mini Plasmid kit (Geneaid) was performed to isolate the mutated 
plasmid. The isolated plasmids were sequenced at the Robarts DNA Sequencing facility to 
confirm the correct insertion-mutation was incorporated at the nucleotide level. The 
sequencing results confirmed that the 2 insertion was incorporated in the correct frame in 
both the pET-28a-STIM1-OASF and pET-28a-STIM2-OASF vectors (Figure 2.1).  
2.1.2 PCR mutagenesis for incorporation of the 2β insert into the 
full-length monomeric cherry fluorescence protein (mCh)-
STIM1 and mCh-STIM2 pCMV6 vectors 
The 2 insertions were incorporated into pCMV6 vectors encoding full-length STIM1 and 
STIM2 proteins each fused to mCh (i.e. pCMV6-mCh-STIM1 and pCMV6-mCh-STIM2) 
essentially as described in Section 2.1.1 with modifications as described below. These 
mammalian expression vectors were from previously published work on STIM1 and 
STIM2 (Stathopulos et al., 2008; Zheng et al., 2011). For these pCMV6-mCh-STIM 
vectors, 20 µL PCR solution mixture was created using 14.65 µL dH2O, 4 µL 5× HF buffer 
(Thermo Fisher Scientific), ~30 ng template pCMV6-mCh-STIM template, ~125 ng 
forward or reverse primer, 1.0 µL DMSO, 0.5 µL of 10 mM dNTPs and 0.25 µL Phusion 
DNA polymerase (Thermo Fisher Scientific). Thermocycling was performed for an initial 
10 cycles of PCR as detailed in Table 2.2. The two mixtures for each of pCMV6-mCh-
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STIM1 and mCMV6-mCh-STIM2 were subsequently combined for a total volume of 50 
µL each and subjected to another 25 cycles of PCR as detailed in Table 2.2. 
Methylated template DNA digestion, transformation into DH5 E. coli, colony picking, 
plasmid propagation and purification was performed as described in Section 2.1.1 for the 
pET-28a-STIM-OASF vectors with the exception that ampicillin was used as the selection 
pressure in LB-agar plates (i.e. 100 g ml-1). The final pCMV6-mCh-STIM1 and pCMV6-
mCh-STIM2 vectors harboring the 2 insertions were confirmed by sequencing at the 
Robarts DNA sequencing facility using the in-house designed primers targeting the OASF 
regions of the full-length STIM1 and STIM2 DNA sequences carried in the pCMV6 
vectors (see Table 2.1).  
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Table 2.1: Oligonucleotide primers used in the research described in this study 
(Sigma-Aldrich St. Louis, MO) 
 
(a)Subcloning primers for STIM1-OASF and STIM2-OASF 
(b)Mutagenesis primer for 2 insert into STIM1-OASF and STIM-OASF 
(c)Sequencing primer   
Primer Sequence 
pET- 28a 
STIM2 
OASF(a) 
        5 – TTTGCTTATGCTAGCAATAAGACATCAAAAGAAC – 3 NHE I 
       5- GGTTTAGCCTCGAGTCAGGGAAAATTGTGACACTATTGG – 3 XHOI 
pET- 28a 
STIM1 2 
OASF(b) 
5 - CTGGTGGCCAAGGAGGGGGTTGCTGCTTCATATCTGATTCAGGCTGAGAAGATAAAAAAG – 3 
3 - CTTTTTTATCTTCTCAGCCTGAATCAGATATGAAGCAGCAACCCCCTCCTTGGCCACCAG – 5 
pET- 28a 
STIM2 
OASF 2β 
Insert(c) 
5 - CTGGTGGCCAAGGAGGGGGTTGCTGCTTCATATCTGATTCAGGCTGAGAAGATAAAAAG – 3 
3 - CTTTTTTATCTTCTCAGCCTGAATCAGATATGAAGCAGCAACCCCCTCCTTGGCCACCAG – 5 
T7 
Terminator(c) 
        5’-GCTAGTTATTGCTCAGCGG-3’ 
T7 
Promoter(c) 
         5′ TAATACGACTCACTATAG 3′  
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Table 2.2:PCR amplification parameters used in LifeECO (Bioer) thermocycler 
 pET28a 
STIM1-
OASF 
Subcloning 
pET28a 
STIM2-
OASF 
Subcloning 
pET28a 
STIM1-
OASF 
mutagenesis 
pET28a 
STIM2-
OASF 
mutagenesis 
pmCherry-
C1 STIM1-
OASF 
mutagenesis 
pmCherry-
C1 STIM2 
mutagenesis 
 35 Cycles 35 Cycles 10 Cycles 
+ 25 
Cycles 
10 Cycles 
+ 25 
Cycles 
10 Cycles 
+ 25 
Cycles 
10 Cycles 
+ 25 
Cycles 
 Temp 
(°C) 
Time 
(Sec) 
Temp 
(°C) 
Time 
(Sec) 
Temp 
(°C) 
Time 
(Sec) 
Temp 
(°C) 
Time 
(Sec) 
Temp 
(°C) 
Time 
(Sec) 
Temp 
(°C) 
Time 
(Sec) 
Initial 
Denaturation 
95 120 95 120 98 30 98 30 98 30 98 30 
Denaturation 95 30 95 30 98 10 98 10 98 10 98 10 
Annealing 55 30 55 30 55.5 30 55.5 30 55.5 30 55.5 30 
Extension 72 198 72 198 72 30 72 30 72 30 72 30 
Final 
Extension 
72 300 72 300 72 30 72 30 72 30 72 30 
Storage 4 ∞ 4 ∞ 4 ∞ 4 ∞ 4 ∞ 4 ∞ 
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2.2 Recombinant protein expression and purification 
2.2.1  pET-28a STIM1-OASF and STIM2-OASF wildtype and 2 
insert mutants 
The pET-28a-STIM1234-491 wildtype (WT) OASF (simplified to “STIM1-OASF” for the 
rest of the thesis) plasmid was transformed using the heat shock method into BL21(DE3) 
E. coli. For this transformation, ~100 ng of vector DNA was mixed with ~50 L of cells 
in an Eppendorf tube on ice for ~20-30 min. Subsequently the tube was heat shocked at 42 
°C for 45 s and placed back on ice for ~2 – 3 min. The cells were subsequently transferred 
into 900 L of LB contained in a 15 mL Falcon tube.  The Falcon tube was incubated at 
37 °C with constant shaking (i.e. 200 rpm) for 60 min. Subsequently, 100 L of the cell 
suspension was plated onto an agar plate containing 60g mL-1 kanamycin as the selection 
pressure. After ~16 h incubation in an air incubator set at 37 °C, one individual colony was 
selected and placed into 30 mL of LB contained in a sterile 250 mL Erlenmeyer flask 
supplemented with 60 µL mg-1 kanamycin. The following day, 5 mL of this liquid starter 
culture was transferred into three autoclaved 4 L flasks each containing 1 L LB and 
supplemented with 60 µg mL-1 of kanamycin.  
The cultures were grown in a New Brunswick™ Excella® E25/E25R incubator shaker at 
37 °C with 190 rpm of constant shaking until an optical density (OD600) reached ~1.0.  At 
this point protein expression was induced with the addition of isopropyl β-D-
1thiogalactopyranoside (IPTG) to a final concentration of 400 M. IPTG is a lactose analog 
which promotes transcription of the insert by binding to the lac repressor and preventing 
its interaction with the lac operator in the pET-28a system. After the IPTG addition, the 
temperature was decreased from 37 °C to 20 °C to minimize protein degradation and 
incubated overnight with 190 rpm constant shaking. The following day, the BL21 E. coli 
cells were collected using a J2-21M Induction drive centrifuge equipped with a JA10 rotor 
(Beckman). The cells were harvested by centrifugation at 9,300 ×g, 4 °C for 30 min. The 
pelleted cells were collected and stored at -80 °C until protein purification.  
WT STIM1-OASF protein was purified from the E. coli cells by homogenizing the ~5 mL 
wet bacterial pellet with 50 mL of 6M guanidine hydrochloride (GdnHCl), 20 mM TRIS-
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HCl (pH 8.0) and 5 mM β – mercaptoethanol (BME) using a 10 mL transfer pipette. 
Sonication was required to completely homogenize small clumps of cells and to shear 
genomic DNA. The bacterial mixture was sonicated on ice at 30% power using the Fisher 
Sonic Dismembrator Model 150 for 5 min in 3 s on and 3 s off cycles. Subsequently, the 
homogenized mixture was attached to a hybridization oven and slowly rotated at ambient 
temperature for 90 min. Following this incubation, the mixture was centrifuged at 11,000 
×g and 8 °C for another 50 min using a JA20 rotor in a J2-21 Induction drive centrifuge 
(Beckman) to separate the insoluble cell debris from the supernatant. Next, ~45 mL of the 
resultant clarified lysate containing solubilized OASF protein was mixed with 300 µL of 
50% (v/v) nickel-nitrilotracetice acid (Ni-NTA) agarose beads (HisPur, ThermoFisher 
Scientific). The Ni-NTA was added to bind to the N-terminally fused hexahistidine 
(6×His)-tag of the OASF protein. The lysate:Ni-NTA mixture was slowly rotated end-over-
end in a 50 mL conical tube overnight at 4 °C to promote maximal binding. The next day, 
the Ni-NTA beads were collected in a gravity flow protein purification column, washed 
three times with 10 mL of 6 M Urea, 20 mM TRIS-HCl (pH 8.0) and 5 mM BME to remove 
weakly bound protein and eluted seven times with 3 mL of 6 M Urea, 20 mM TRIS-HCl 
(pH 8.0), 5 mM BME and 300 mM imidazole. Each elution aliquot was incubated for 90 s 
to maximally displace the 6×His-OASF protein from the beads 
The presence of the protein in the elution fractions was confirmed by separating aliquots 
of each fraction on a 15 % (w/v) SDS-PAGE gel, followed by Coomassie blue staining 
(Figure 2.2A). Elution fractions that contained the protein of interest (~15-20 mL) were 
pooled together into a 3,500 Da molecular weight cutoff dialysis membrane (BioDesign 
Inc.) and placed into 1 L protein refolding buffer containing 20 mM TRIS-HCl (pH 8), 300 
mM NaCl, 1 mM dithiothreitol (DTT). 
A magnetic stir bar was used to ensure homogeneous exchange between the unfolding 
buffer contained in the dialysis bag and the bulk folding buffer in the beaker. Refolding 
progressed overnight at 4C. Following ~16 h, 1U of bovine thrombin (BioPharm 
Laboratories, Inc) per mg of protein was added to the dialysis bag and placed at 4C for 
another ~24 h of dialysis. The cutting efficiency of thrombin was determined using a 15 % 
(w/v) SDS-PAGE gel by comparing the migration of OASF before and after the addition 
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of thrombin (Figure 2.2C). Upon verification of removal of the 6×His tag, 100 µM of 4-
(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) was added to the sample to stop 
thrombin activity. 
To achieve ~95% purity, a final size exclusion chromatography purification was performed 
to separate contaminants by size. This gel filtration was performed using a HiLoad 
Superdex S200 20/60 PG column connected to an ÄKTA Pure system (GE Healthcare). 
The running buffer used in this purification step was 20 mM TRIS, 1 mM DTT and 300 
mM NaCl (pH 8.0) which was equilibrated into the 325 mL Hiload column prior to 
injecting the refolded OASF protein concentrated to ~8-10 mL. Furthermore, OASF was 
eluted in 1 mL fractions, collected in a 96× deep well plate. Elution was monitored by UV 
absorbance at 280 nm (Figure 2.3A). Fractions which showed UV 280 nm absorbance were 
then separated on a 15 % (w/v) SDS-PAGE gel to confirm the presence of STIM1-OASF 
and purity after Coomassie blue staining (Figure 2.3C). Fractions which showed a single 
band migrating near the theoretical molecular weight of the monomer were pooled and 
stored at 4 °C for experiments performed within 2 days or flash frozen with liquid nitrogen 
and housed at -80 °C for long term storage.  
STIM1-2-OASF, STIM2-OASF and STIM2-OASF proteins were expressed and 
purified as exactly as detailed above for STIM1-OASF (Figure 2.2, Figure 2.3, Figure 2.4 
and Figure 2.5). Protein concentration was determined using UV extinction coefficients of 
0.9478, 0.9629, 0.9948 and 1.0088 mg mL-1 cm-1 at 280 nm for STIM1-OASF, STIM1-
2-OASF, STIM2-OASF and STIM2-OASF, respectively.  
  
BA
STIM1-2
STIM1
STIM1-2
STIM1
STIM2
STIM2
Figure 2.1. Pairwise alignment of the sequenced DNA showing successful 2 insertion. (A)
depicts STIM1-2 insert in comparison to STIM1 (Accession: AFZ76986.1) and (B) shows
STIM2 in comparison to STIM2 (Accession: NP_065911.3).
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Figure 2.2. Coomassie blue R-250 staining of STIM1-OASF and STIM1-2-OASF separated
on 15% (w/v) SDS-PAGE gels. (A) 6×His-STIM1-OASF (theoretical monomer weight of 33
kDa) Ni-NTA elution fractions. (B) 6×His-STIM1-2β-OASF (theoretical monomer weight of
33kDa) Ni-NTA elution fractions. (C) Pre- and post-thrombin samples indicate the migration
of the protein samples with presence and absence of the 6×His tag corresponding to 33 kDa
and 31 kDa for STIM1-OASF; (D) 33 kDa and 32 kDa for STIM1-2-OASF, respectively.
The reference proteins are from the PageRulerTM Broad Range Unstained Protein Ladder
(ThermoFisherScientific).
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Figure 2.3. Superdex S200 HiLoad 10/60 size exclusion chromatography elution profile of
(A) STIM1-OASF and (B) STIM1-2-OASF. The elution profile was generated using
absorbance at 280 nm as a function of elution volume. Coomassie blue R-250 staining of (C)
STIM1-OASF (theoretical monomer weight of 31 kDa) and (D) STIM1-2β-OASF
(theoretical monomer weight of 32 kDa) separated on a 15% (w/v) SDS-PAGE gel. The
reference lane contains the PageRulerTM Broad Range Unstained Protein Ladder.
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Figure 2.4. Coomassie blue R-250 staining of STIM2-OASF and STIM1 2 insert- OASF
separated on 15% (w/v) SDS-PAGE gels. (A) 6×His-STIM2-OASF (theoretical monomer
weight of 33 kDa) Ni-NTA elution fractions. (B) 6×His-STIM2β-OASF (theoretical monomer
weight of 33kDa) Ni-NTA elution fractions. (C) Pre- and post-thrombin samples indicate the
migration of the protein samples with presence and absence of the 6×His tag corresponding to
33 kDa and 31 kDa for STIM2-OASF; (D) 33 kDa and 32 kDa for STIM2β-OASF,
respectively. The reference proteins are from the PageRulerTM Broad Range Unstained
Protein Ladder (ThermoFisherScientific).
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Figure 2.5. Superdex S200 HiLoad 10/60 size exclusion chromatography elution profile of
(A) STIM2-OASF and (B) STIM2β-OASF. The elution profile was generated using
absorbance at 280 nm as a function of elution volume. Coomassie blue R-250 staining of
(C) STIM2-OASF (theoretical monomer weight of 31 kDa) and (D) STIM2β-OASF
(theoretical monomer weight of 32 kDa) separated on a 15% (w/v) SDS-PAGE gel. The
reference lane contains PageRulerTM Broad Range Unstained Protein Ladder.
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2.3  Far-UV circular dichroism (CD) spectroscopy 
To assess the effects of the 2 insert on the secondary structure and thermal stability of the 
OASF proteins, far-UV CD spectroscopy was used. All far-UV CD experiments were 
performed using a Jasco J-815 CD spectrometer equipped with a Jasco PTC-423S 
temperature controller (Jasco Inc.). To prepare a far-UV CD sample, dilute protein 
solutions were first concentrated using an Amicon Ultra-15 centrifugal filter unit (10,000 
MWCO) (Millipore) and UV absorbance at 280 nm was used to determine the protein 
concentration after centrifugation at 10,000 ×g for 10 min to remove precipitate. Based on 
this stock concentration, a 275 L sample of 0.2 mg mL-1 protein was prepared by dilution 
in experimental buffer and transferred into a 0.1 cm pathlength quartz cuvette. 
Experimental buffer was 20 mM TRIS, 1 mM DTT and 300 mM NaCl, pH 8.0. Separate 
samples were also prepared in the presence of Ca2+ with the addition of 25 mM Ca2+ from 
a 1 M CaCl2 stock  
 
Far-UV CD spectra were acquired at 20 °C as an average of 3 accumulations between 240 
nm to 200 nm in 1 nm increments using the 0.1 cm pathlength quartz cuvette, 8 s averaging 
time at each wavelength, 1 nm bandwidth. Moreover, thermal melt curves were acquired 
by monitoring the change CD signal at 222 nm as a function of temperature also using the 
0.1 cm pathlength quartz cuvette, an averaging time of 8 s, 1 nm bandwidth and a 1 C min-
1 scan rate. The thermal melt samples were prepared as described for the UV spectrum 
samples. The apparent midpoint of temperature denaturation (Tm) was used as an indicator 
of thermal stability. Tm was taken as the point of 50 % relative change in ellipticity at 222 
nm.  
2.4  8- Anilinonaphthalene-1-sulfonic acid (ANS) 
binding assay 
The relative levels of hydrophobic exposure for the OASF proteins were assessed using 
ANS, a fluorescence probe which undergoes a change in fluorescence when bound to 
solvent-exposed hydrophobic protein regions. The extrinsic ANS fluorescence intensity 
was detected using a Cary Eclipse spectrofluorimeter (Varian/Agilent, Inc). The 
experimental buffer was 20 mM TRIS, 300 mM NaCl, 1 mM DTT, pH 8.0. The protein 
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samples were prepared at a final concentration of 0.143 mg mL-1 in 600 L total volume.  
Samples were supplemented with 0.5 mM EDTA to chelate residual Ca2+ and ANS was 
added to a final concentration of 10 M. The extrinsic ANS fluorescence emission 
spectrum was acquired at 35 C from 400 nm to 600 nm using an excitation wavelength of 
372 nm. The excitation and emission slit widths were set to 10 nm and 20 nm, respectively, 
while the photomultiplier tube (PMT) was set to 680 V. Control spectra were acquired in 
the absence of protein using similar settings and buffer conditions. Ca2+ was titrated into 
the protein-containing and protein-free control samples with successive additions of 5 mM 
CaCl2 from a 1 M CaCl2 stock. 15 min incubation between CaCl2 aliquots was determined 
to be sufficient for binding equilibration. 
2.5  Size-exclusion chromatography with in line multi-
angle light scattering (SEC-MALS) 
The quaternary structure of the OASF proteins was assessed using SEC-MALS. 125 L of 
the OASF proteins at 1 mg mL-1 protein were injected onto a Superdex 200 increase 10/300 
GL gel filtration column (GE Healthcare) using the AKTA Pure system (GE Healthcare). 
The column was connected in line to a Dawn HELEOS II MALS detector equipped with a 
662 nm laser source and Optilab Trex differential refractometer equipped with 658 nm 
LED source (Wyatt Technology). The SEC-MALS system was housed in a cold-cabinet 
maintaining a temperature of 10 °C.  
The SEC-MALS experimental buffer was 20 mM TRIS, 1 mM DTT and 150 mM, pH 8.0 
supplemented with or without 25 mM CaCl2, as specified. Protein concentrations through 
the eluted peaks were determined by the differential refractometer using a refractive index 
increment of dn·dc-1 = 0.185 mL·g-1. Samples were eluted at a flow rate of 0.5 mL min-1 
and molecular weights were calculated by Zimm plot analysis using the ASTRA software 
(v6.1.5.22; Wyatt Technologies). 
2.6 Dynamic Light Scattering (DLS) 
The distribution of hydrodynamic radii of OASF protein solutions were determined by 
DLS. The DLS experiments were performed on a DynaPro Nanostar (Wyatt Technology) 
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equipped with a 658 nm laser. The experimental buffer was 20 mM TRIS, 1 mM DTT and 
300 mM NaCl, pH 8.0. DLS samples were prepared by centrifuging 0.5 mg mL-1 protein 
solutions at 12,000 ×g for 3 min, to remove any large particulates which can dominate DLS 
signal, before a 5 μL aliquot was loaded into a dust-free quartz MicroCuvette (JC501). All 
DLS acquisitions were performed at 37 °C, where the protein sample was allotted 5 min of 
equilibrium time prior to acquiring 10 consecutive readings averaged over 5 s. 
Furthermore, distributions of hydrodynamic radii were extracted from the autocorrelation 
function using the regularization algorithm for polydisperse solutions built into the 
accompanying instrumental software (Dynamics v7; Wyatt Technologies). The low and 
high cut-off for hydrodynamic size was set to 1.5 nm and 150 nm, respectively.  
2.7  Solution Small Angle X-ray Scattering (SAXS)  
To assess the effects of the 2 insert on the overall structure of STIM1-OASF and STIM2-
OASF in solution, SAXS data was acquired. Protein solutions for of each OASF constructs 
were prepared at the highest possible concentration which did not readily precipitate. These 
concentrations were 1.041 mg mL-1, 0.855 mg mL-1, 1.045mg mL-1 and 1.109 mg mL-1 for 
STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF, respectively. Flow 
through samples collected during the ultrafiltration concentration procedure for each 
protein were used as the buffer controls. SAXS profiles for the protein and matching buffer 
controls were acquired by Dr. Gregory A. Wasney (Structural & Biophysical Core Facility, 
The Hospital for Sick Children, Toronto, ON). Measurements were performed in a 1 mm 
quartz cuvette (50 μL) at 4 °C using a 3 h X-ray exposure time (180 × 1 min frame). An 
aligned SAXSpace instrument (Anton PaarGmbH) working in line collimation mode was 
used to carry out the assessment. The SAXSpace X-ray generator contained a long-fine 
focus glass sealed copper tube (40 kV/50 mA, wavelength = 0.1542 nm), and the detector 
used was a Mythen2 R 1K 1D detector (DECTRIS Ltd). Sample cuvette temperature was 
regulated using a Peltier-controlled TCStage150. 
 
The buffer-subtraced SAXS profiles were used to calculate the experimental radius of 
gyration (Rg), distance-distribution function p(r) and reconstruct a low-resolution structure. 
Experimental Rg was calculated as √(3×slope) of the Guinier plot constructed as the natural 
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log of the intensity [ln(I)] versus the square of scattering vector (s2) (Boldon et al., 2015; 
Putnam, 2016). The maximum particle diameter (Dmax) was determined from the pair 
distance-distribution function [p(r)], initially estimated using DATGNOM, and then 
manually adjusted until a gradual decay to zero was observed in the p(r) function. The Dmax 
was used in ab initio shape reconstruction using DAMMIF. Thirty DAMMIF ab initio 
structures were determined for each OASF protein. These thirty structures were clustered 
and averaged using DAMCLUST(Franke et al., 2009; Petoukhov et al., 2012; Maxim V. 
Petoukhov et al., 2007). The resultant bead models were visualized using PYMOL.(Cui et 
al., 2013; Stathopulos et al., 2013)  
2.8  Human embryonic kidney (HEK) 293 cell culture 
HEK293 cells stably expressing yellow fluorescent protein (YFP)-Orai1 were a generous 
gift from the laboratory of Dr. Monica Vig (Washington University in St. Louis). These 
adherent cells were cultured in Dulbecco’s modified eagle media (DMEM) containing high 
glucose (Wisent) and supplemented with 10 % (v/v) fetal bovine serum (Wisent), 100 μg 
– 100 U ml-1 penicillin-streptomycin (Wisent) and 0.4 mg ml-1 G418 disulfate (Thermo 
Fisher Scientific). Cells were grown on 10 cm dishes and maintained at 37 °C in a 5 % 
(v/v) CO2 / 95 % (v/v) air mixture within a humidified incubator. At ~ 85% - 90 % cell 
confluency, the culture medium was removed and 10 mL of 1× PBS was promptly added 
to the dish. The PBS was subsequently removed and 1 mL of 0.25 % trypsin with 2.21 mM 
EDTA (Wisent) was immediately distributed over the entire surface of the dish. The cells 
were incubated in the presence of the trypsin for ~2 - 3 min at 37 °C. Subsequently, 9 mL 
of DMEM medium containing FBS and antibiotic was added to the dish and thoroughly 
mixed using a transfer pipette to ensure complete detachment of cells from the dish surface. 
To conduct a 25 % cell passage, 2.5 mL of the trypsinized cell mixture was aliquoted into 
a sterile 10 cm cell culture dish containing 7.5 mL DMEM high glucose medium 
supplemented with FBS and antibiotic as detailed above.  
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2.9 Transfection of HEK293 with pCMV6-mCh-STIM 
vectors 
After 20 – 24 h, at ~70 – 80 % confluency, HEK293 cells were transiently transfected with 
the pCMV6-mCh-STIM1, STIM2, STIM1-2 or STIM2 vectors using PolyJetTM 
transfection reagent (Froggabio) according to the manufacturers protocol. Briefly, 5 g of 
DNA was diluted in 250 L of high glucose DMEM which was free of antibiotics and FBS. 
Similarly, 15 µL of PolyJetTM reagent was also diluted in 250 L of high glucose DMEM 
medium free of antibiotic and FBS. The diluted PolyJetTM reagent was immediately 
transferred into the diluted DNA solution and mixed ~3 – 4 times by pipetting. The 
PolyJet:DNA mixture was subsequently incubated at room temperature for 15 min. Finally, 
the 500 L transfection mixture was added in a drop-wise manner evenly over the cell 
culture dish containing the adherent HEK293 cells in the complete culture medium (i.e. 
with antibiotic and FBS). The cells were incubated at 37 °C for 24 h prior to use in the 
SOCE experiments (see below).  
2.10  Fura-2 ratiometric fluorescence spectroscopy to 
assess SOCE 
Transfected HEK293 cells were lifted off the cell culture dish by gentle pipetting and 
transferred into a 15 mL conical tube. Fura-2 acetoxymethyl ester (AM) was added to a 
final concentration of 2 M, and the cell suspension was mixed by gentle inversion. The 
cells were placed at 37 °C for a total of 45 min with mixing by inversion every 15 min. The 
cells were subsequently pelleted through centrifugation at 300 ×g for 3 min, the medium 
was aspirated out of the tube and the cells resuspended in 14 mL of Ca2+-free HEPES 
buffered saline solution (HBSS) composed of 140 mM NaCl, 5 mM KCl, 10 mM D-
glucose, 1 mM MgCl2 and 10 mM HEPES, pH 7.4. The suspended cells were then 
centrifuged at 300 ×g for another 3 min and this wash solution was removed by aspiration. 
The resultant cell pellet was homogeneously resuspended in a final 1.2 mL of Ca2+ free 
HBSS and transferred into a quartz cuvette. The 1.2 mL cell suspension was supplemented 
with a final concentration of 0.5 mM ethylene glycol tetraacetic acid (EGTA) to chelate 
any residual Ca2+. The resuspended HEK293 cells were incubated for 3 min at 25 °C in the 
44 
 
Cary Eclipse spectrofluorimeter (Varian/Agilent, Inc.) before measuring the Fura-2 
fluorescence.  
SOCE was assessed using Fura-2 ratiometric fluorescence measurements. Fura-2 
fluorescence was measured using alternating excitation wavelengths of 340 and 380 nm 
and an emission wavelength of 510 nm. After a 100 s baseline acquisition, 2 M of 
thapsigargin (TG) was added to passively deplete ER Ca2+ by blockade of the SERCA 
pumps. At 600 s, 2.5 mM of CaCl2 was added to the cell suspension to induce Ca2+ entry 
into the cytosol from the extracellular space. The excitation and emission slit widths used 
in these Fura-2 experiments were 5 nm and 10 nm, respectively, and the PMT was set to 
650 V.  
To assess the relative transfection efficiencies and cell densities, mCh and YFP 
fluorescence of the cell suspensions were measured. For transfection efficiency 
assessment, mCh fluorescence emission spectra were acquired between 580 – 680 nm using 
an excitation wavelength of 565 nm at 25 °C. YFP-Orai fluorescence was taken as an 
indicator of cell density. YFP fluorescence emission spectra were acquired from 510 nm 
to 620 nm using an excitation wavelength of 490 nm. Excitation and emission slit widths 
were set to 10 nm and 20 nm, respectively, while the PMT was set to 650 V.  
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3 Chapter 3: Results 
3.1 The 2 insertion decreases the -helicity of OASF 
Secondary structure prediction using PSIPRED (McGuffin et al., 2000), suggests that the 
2 insert is unstructured within STIM2, and this lack of regular secondary structure could 
very well affect the overall structural integrity of the OASF domains. However, the precise 
effects of the 8-amino acid insert (i.e. 2insert) on the folding and stability of the 
conserved CC domains remains poorly understood. To assess the effects of the 2 insert 
on protein structure and stability, I used far-UV CD spectroscopy to monitor the secondary 
structure and unfolding as a function of temperature. CC domains typically adopt extended 
-helical structures, so I expected two intensity minima at 208 nm and 222 nm indicative 
of -helicity in the far-UV CD spectra of the OASF proteins (Correcirc et al., 2009). 
Indeed, my far-UV CD data showed that all STIM-OASF homologues and the 
corresponding 2 variants exhibited minima at 208 nm and 222 nm indicating they retain 
a high fraction of -helicity even in the presence of the 2 insertion. Nevertheless, after 
normalizing the CD signal on a per residue basis, it was clear that inclusion of the 2 insert 
reduced the overall -helicity, indicated by less negative ellipticity compared to the WT 
homologues (Figure 3.1). Thus, the 2 insert significantly reduces the overall -helicity of 
the STIM1-OASF and STIM2-OASF regions.   
A B
C D
Figure 3.1. The 2 insertion decreases -helicity of the OASF regions of STIM1 and
STIM2. Far-UV CD spectra of STIM1-OASF (A) and STIM2-OASF (B) with and without
the 2β insertions. Statistical analysis of (C) STIM1-OASF and (D) STIM2-OASF a-helicity
at 222 nm using an unpaired student’s t-test. All experiments were performed using 0.2 mg
ml-1 protein concentration. Inclusion of 2β results in less negative ellipticity compared to
unmodified STIM OASF at 208 nm and 222 nm suggesting less α-helicity. Data are means ±
SEM of n = 3 separate protein purifications (*p < 0.05 vs wildtype).
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3.2 The 2 insertion reduces the thermal stability of 
STIM1-OASF 
Having determined that the 2 insert affects the overall level of secondary structure within 
OASF, I next assessed the thermal stability by monitoring the change in far-UV CD signal 
at 222 nm as a function of temperature. The apparent midpoint of temperature denaturation 
(Tm) was taken as the temperature causing a 50 % change in the CD signal. In the STIM1-
OASF context, the 2 insert induced a systematic leftward shift in the thermal melt profile 
(Figure 3.2A). The apparent Tm for STIM1-2-OASF was 47.1 ± 0.1 °C compared to 50.5 
± 0.2 °C for STIM1-OASF. The significant reduction in Tm (i.e. Tm = ~ -3 °C, **p < 0.01) 
shows that the 2 insert destabilizes the STIM1-OASF region (Figure 3.2B). 
The STIM2-OASF thermal melts exhibited less well-defined folded baselines compared to 
the STIM1-OASF data (Figure 3.2A and Figure 3.2B), likely due to a poorer cooperativity 
of STIM2 CC domain unfolding. While the 2 insert did not induce a statistically 
significant change in Tm as defined in this thesis (i.e. ΔTm = ~ -1 °C, p > 0.05, for STIM2-
OASF compared STIM2-OASF), the first unfolding transition appeared complete at a 
much earlier temperature (i.e. ~48 °C versus ~58 °C, for STIM2 versus STIM2-OASF, 
respectively) (Figure 3.2B and 3.2D). The second transition likely represented a protein 
aggregation and/or precipitation phase. Interestingly, the STIM2-OASF is markedly less 
stable than STIM1-OASF (i.e. ΔTm = ~-6 °C) which may be related to its weaker ability to 
activate SOCE. Collectively, the thermal stability data show that the 2 insert causes 
destabilization of STIM1-OASF (Table 3.1) and alters the thermal unfolding profile for 
STIM2-OASF such that the first unfolding transition is completed at a much lower 
temperature.   
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Table 3.1: Summary of the thermal stabilities for STIM1-OASF and STIM2-OASF 
with their respective 2 insertions 
Statistical analysis was performed using an unpaired two-tailed student’s t-test  
**p < 0.01 vs WT STIM1-OASF and STIM2-OASF  
Protein Apparent Tm (°C) ΔTm 
STIM1-OASF 50.5 ± 0.2  
STIM1-2-OASF 47.1 ± 0.1 ** -3.4 °C 
STIM2-OASF 44.0 ± 0.4  
STIM2-OASF 42.6 ± 0.9 -1.4 °C 
A B
C D
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Figure 3.2. The 2 insertion reduces the thermal stability of STIM1-OASF. Far-UV CD
thermal melts of STIM1-OASF (A), STIM1 2-OASF (B), STIM2-OASF (C), and STIM2-
OASF (D), The 2 insert causes a significant thermal destabilization of STIM1-OASF.
Additionally, the 2 insert alters the unfolding profile of STIM2-OASF such that the first
transition is apparently complete at a much earlier temperature for STIM2 compared to
STIM2. Data are means ± SEM of n = 3 separate protein purifications (**p < 0.01 vs
wildtype).
50 
 
3.3 Calcium (Ca2+) induces an increase in hydrophobic 
exposure which is exacerbated by 2 
Previous work showed that STIM1-OASF contains potential inhibitory Ca2+ binding sites 
which disrupt CC interactions important for mediating SOCE activity (Derler et al., 2009). 
This inhibitory domain contains a cluster of several negatively charged residues, conserved 
in both STIM1 and STIM2, which complement the positive charge of Ca2+ (Figure 3.3A). 
Having determined that the 2 insert decreases the folding and stability of OASF, I next 
assessed whether the insert alters how Ca2+ affects the conformation of OASF. I used an 8-
anilinonaphthalene-1-sulfonic acid (ANS) binding assay to probe OASF conformation.  
I measured the ANS fluorescent intensity of STIM1-OASF, STIM1-2-OASF, STIM2-
OASF and STIM2-OASF as a function of increasing Ca2+ concentration. The ANS 
fluorescence intensity for all OASF proteins showed an increase in ANS fluorescence 
intensity and a shift to lower wavelengths in the emission maxima, indicative of greater 
exposed hydrophobicity in the presence of Ca2+ compared to the spectra acquired with no 
Ca2+ (Figure 3.3B, Figure 3.3C, Figure 3.3D and Figure 3.3E). For STIM1-OASF and 
STIM2-OASF, the increase ANS fluorescence trended toward, but did not reach saturation 
in a titration between 0 – 40 mM CaCl2 (Figure 3.3B and Figure 3.3C). In contrast, the 
fluorescence intensity of the OASF proteins containing the 2 insert reached apparent 
saturation over a similar 0 – 40 mM CaCl2 concentration range (Figure 3.3D and 3.3E). 
The conformational sensitivity of all OASF proteins to CaCl2 supports the existence of 
Ca2+ binding site(s) which remain accessible and intact in the 2 variants.  
Interestingly, the ANS fluorescence intensity was higher with the STIM1-2-OASF and 
STIM2-OASF proteins compared to the STIM1-OASF samples which did not include the 
2 insert (Figure 3.4). Specifically, the ANS fluorescence intensity was 392.4 ± 3.59 A.U. 
compared to 484.9 ± 2.61 A.U. in the presence of STIM1-OASF and STIM1-2-OASF, 
respectively (**p < 0.01).  
This trend in ANS fluorescence was maintained at the highest CaCl2 concentration, with 
the protein samples containing the 2 insert showing higher fluorescence intensity 
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compared to protein samples without the 2 insert (Figure 3.4 and Table 3.2). Additionally, 
the magnitude of the change in ANS fluorescence as a function of CaCl2 was smaller for 
both STIM1-OASF and STIM2-OASF compared to STIM1-2-OASF and STIM2-OASF 
(Figure 3.4 and Table 3.2).  
Taken together, my ANS experiments suggests that the 2 insert increases the exposed 
hydrophobicity of STIM1-OASF and STIM2-OASF, and this conformational change alters 
the Ca2+ binding properties of the domain such that the maximal change in conformation 
is reached at lower Ca2+ concentrations for OASF proteins containing the 2 insertion. 
Importantly, the higher ANS fluorescence observed for protein samples containing the 2 
insert is consistent with the decreased folding and stability described above.  
CA
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D
7 negatively charge residues for STIM1
E
5 negatively charge residues for STIM2
Figure 3.3. Ca2+ induces an increase in exposed hydrophobicity in the STIM OASF
domains which is exacerbated by the 2 variation. (A) Seven and five negatively charged
residues in STIM1 and STIM2, respectively, which can act as potential Ca2+ binding sites.
Extrinsic ANS-binding induced fluorescence emission spectra of STIM1-OASF (B),
STIM1-2β-OASF (C), STIM2-OASF (D) and STIM2β-OASF (E) as a function of
increasing CaCl2. For all samples, fluorescence intensity increased and exhibited a
concomitant blue shift in the emission maximum with increasing CaCl2 concentrations. Data
are means ± SEM of n = 3 separate protein purifications.
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Figure 3.4. The 2 insert promotes apparently saturable Ca2+ binding within STIM2-
OASF which enhances solvent exposed hydrophobicity. The change in maximum ANS-
binding induced fluorescence emission of STIM1-OASF (blue), STIM1-2β-OASF (red),
STIM2-OASF (green) and STIM2β-OASF (purple) is shown as a function of CaCl2
concentration. At each CaCl2 concentration, data are means ± SEM of n = 3 separate protein
purifications.
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Table 3.2:Summary of basal ANS fluorescence and saturated ANS fluorescence of 
STIM1-OASF and STIM2-OASF with their respective 2 insertions 
(a) Extrinsic ANS fluorescence measured at baseline (i.e. 0 mM Ca2+)  
(b) Extrinsic ANS fluorescence measured at the saturation point for each respective protein  
(c) Change in extrinsic ANS fluorescence obtained by taking the difference between extrinsic ANS 
fluorescence measured at saturation and baseline  
Statistical analysis was performed using an unpaired two-tailed student’s t-test comparing 
the basal ANS fluorescence and saturated ANS fluorescence of the 2insertions variants to 
wildtype STIM1-OASF and STIM2-OASF 
*p < 0.05, **p < 0.01, ***p <0.001 vs WT STIM1-OASF and STIM2-OASF 
  
Protein Basal 
Fluorescence(a) 
Saturated 
Fluorescence(b) 
Fluorescence(c) 
STIM1-OASF 392.4 ± 3.59 
 
615.8 ± 11.65 
 
+223 
STIM1-2-OASF 484.9 ± 2.61 ** 
 
792.8 ± 11.74 *** 
 
+308 
STIM2-OASF 321.4 ± 13.72 
 
612.9 ± 47.14 
 
+292 
STIM2-OASF 709.1 ± 4.52 ** 
 
887.8 ± 30.65 * 
 
+179 
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3.4 Ca2+ minimally affects the -helicity of the OASF 
domains with or without 2 
Given my ANS data which indicated that Ca2+ induces a conformational change in all the 
STIM OASF proteins, both with and without the 2 insert, I next assessed whether this 
conformational change is coupled to changes in secondary structure. I used far-UV CD 
spectroscopy to assess -helicity. Interestingly, the addition of 25 mM CaCl2 to the 
STIM1-OASF and STIM1-2β-OASF proteins resulted in CD spectra which showed a trend 
to less negative ellipticity at both the 208 and 222 nm minima (Figure 3.5A and Figure 
3.5C). However, this apparent loss in -helicity was relatively small and not statistically 
significant (Figure 3.5B and Figure 3.5D). Similarly, STIM2-OASF and STIM2-OASF 
protein showed no statistically significant change in negative ellipticity in the presence of 
25 mM CaCl2 (Figure 3.5E, Figure 3.5F, Figure 3.5G and Figure 3.5H).  
Collectively, the far-UV CD spectra show that Ca2+ minimally affects the secondary 
structure levels of STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF. 
Thus, the Ca2+-induced conformational changes observed by ANS binding in all OASF 
proteins are not linked with major changes in -helicity.   
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Figure 3.5: Ca2+ causes only minor changes in the secondary structure levels of the 
human OASF domains. Far-UV CD spectra of STIM1-OASF (blue circle) (A and B), 
STIM1-2-OASF (red circle) (C and D), STIM2-OASF (green circles) (E and F) and 
STIM2-OASF (purple circle) (G and H). The spectra acquired in the Ca2+-loaded 
conditions are shown as black open symbols and checkered patterns in the UV spectra and 
bar graphs, respectively. Data are means ± SEM of n = 3 separate protein preparations (p 
> 0.05 compared Ca2+ free conditions for all comparisons).   
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3.5 Ca2+ thermally destabilizes STIM1-OASF and 
STIM1-2 OASF 
Next, I monitored changes in far-UV CD signal at 222 nm as a function of temperature to 
assess whether Ca2+ affects the thermal stability of the OASF proteins. Consistent with the 
trend to lower -helicity observed for both STIM1-OASF and STIM1-2-OASF (see 
above), both these proteins exhibited decreased thermal stabilities in the presence of 25 
mM CaCl2. STIM1-OASF showed a Tm of 47.1 ± 0.2 °C in the presence of CaCl2 and a Tm 
of 50.5 ± 0.2 °C in the absence of CaCl2 (i.e. Tm = ~ -3 °C, **p < 0.01) (Figure 3.6A and 
Figure 3.6B). Similarly, STIM1-2-OASF showed a Ca2+-induced destabilization as the 
apparent Tm was 42.3 ± 0.6 °C in the presence of CaCl2 compared to 46.8 ± 0.1 °C in the 
Ca2+-free conditions (i.e. Tm = ~ -5 °C, *p < 0.05) (Figure 3.6C and Figure 3.6D) (Table 
3.3).  
 
In contrast to the STIM1 data, STIM2-OASF showed no significant differences in apparent 
Tm in the presence of 25 mM CaCl2 compared to the absence of CaCl2. Specifically, the Tm 
of STIM2-OASF was 45.0 ± 0.4 °C with CaCl2 compared to 46.6 ± 0.5 °C without CaCl2 
(i.e. Tm = ~ +1 °C, p > 0.05) (Figure 3.6E and Figure 3.6F). Similarly, the addition of 
CaCl2 to the STIM2-OASF sample did not significantly alter the Tm. The Tm was 41.2 ± 
0.9 °C for STIM2-OASF in presence of CaCl2 compared to 42.6 ± 0.9 °C in the absence 
of CaCl2 (i.e. Tm = ~ +1 °C, p > 0.05) (Figure 3.6G and Figure 3.6H) (Table 3.3).  
 
Together, the thermal stability data suggest that Ca2+ significantly destabilizes STIM1-
OASF and STIM1-2-OASF but does not significantly affect STIM2-OASF and STIM2-
OASF stability. These differences could reflect discrepancies in the structures adopted by 
the STIM1-OASF compared to STIM2-OASF (see below). 
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Figure 3.6: Ca2+-induces destabilization of STIM1-OASF and STIM1-2-OASF 
proteins. Far-UV CD thermal melts of STIM1-OASF (A and B), STIM1-2-OASF (C and 
D), STIM2-OASF (E and F) and STIM2β-OASF (G and H) in the presence and absence 
of 25 mM CaCl2. Data acquired in the presence of CaCl2 are shown with open symbols. 
Data are means ± SEM of n = 3 separate protein preparations (*p < 0.05, ** p < 0.01 vs 
Ca2+ free conditions. Ca2+ data points are replotted from figure 3.2.  
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Table 3.3: Summary of the thermal stabilities for STIM1-OASF, STIM1-2-OASF, 
STIM2-OASF and STIM2-OASF in the presence and absence of high Ca2+ 
Statistical analysis was performed using an unpaired two-tailed student’s t-test  
*p < 0.05, **p<0.01 vs Ca2+ free conditions  
Protein Buffer Condition Apparent Tm °C 
(Mean ± SEM) 
Tm °C 
 
STIM1-OASF 
Ca2+ free (n = 3) 
 
Ca2+ loaded (n = 3) 
50.5 ± 0.2 
 
47.1 ± 0.2** 
 
-3.4 °C 
 
STIM1-2-OASF 
 
Ca2+ free (n = 3) 
 
Ca2+ loaded (n = 3) 
46.8 ± 0.1 
 
42.3 ± 0.6* 
 
-4.5 °C 
 
STIM2-OASF 
Ca2+ free (n = 3) 
 
Ca2+ loaded (n = 3) 
45.0 ± 0.4 
 
46.6 ± 0.5 
 
+1.6 °C 
 
STIM2-OASF 
Ca2+ free (n = 3) 
 
Ca2+ loaded (n = 3) 
42.6 ± 0.9 
 
41.2 ± 0.9 
 
+1.4 °C 
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3.6 STIM1-OASF, STIM1-2-OASF and STIM2-OASF 
undergo a Ca2+-dependent increase in aggregation 
propensity 
STIM-mediated activation of Orai1 channels requires oligomerization by both the N-
terminal luminal domains and the cytosolic CC domains (Stathopulos et al., 2013; 
Stathopulos et al., 2009; Stathopulos et al., 2008; Zheng et al., 2008). These 
oligomerization events are linked to the conformational extension within the cytosolic 
domains of STIM which ultimately promotes interactions with phosphoinositides and 
Orai1 subunits on the PM (DeHaven et al., 2007; Enomoto et al., 2017; Korzeniowski et 
al., 2010; Muik et al., 2009). Thus, I next assessed the oligomerization propensity of the 
OASF proteins by DLS.  
I first assessed Ca2+-induced changes in oligomerization. In the absence of Ca2+, STIM1-
OASF showed a major distribution of hydrodynamic radii (Rh) centered at ~3.48 nm. 
Similarly, the STIM1-2-OASF variant showed the major distribution of Rh values 
centered at ~4.10 nm. Upon addition of 25 mM CaCl2, both STIM1-OASF and STIM1-2-
OASF exhibited a large fraction (i.e. > 25 % by mass) of higher order oligomers with Rh 
greater than 100 nm (Figure 3.7A and Figure 3.7B).  
Interestingly, STIM2-OASF was found to be in a largely aggregated state with most 
particles exhibiting Rh of > 100 nm (i.e. > 90 % by mass). Remarkably, STIM2-OASF 
showed a lower propensity for oligomerization with most particles exhibiting an Rh of 4.10 
nm, similar to the distribution observed for STIM1-2-OASF. Upon addition of 25 mM 
CaCl2, STIM2-OASF maintained its largely aggregated state, while the majority of the 
STIM2-OASF protein was converted to larger aggregates (i.e. > 100 nm) (Figure 3.7C 
and 3.7D). 
Taken together, the DLS data show that Ca2+ induces and/or favours higher order 
oligomerization of STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF. 
Additionally, the data revealed that incorporation of the 2β variation into either the STIM1-
OASF or STIM2-OASF context promotes similar oligomerization states in the presence 
and absence of Ca2+. This effect on oligomerization is most noticeable in the STIM2-OASF 
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context where STIM2-OASF is largely oligomerized whereas STIM2-OASF shows a 
much smaller distribution of Rh which closely matches STIM1-2β-OASF (Figure 3.8A and 
Figure 3.8B).  
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Figure 3.7. Ca2+ promotes aggregation of STIM1-OASF, STIM1-2-OASF, STIM2-
OASF and STIM2-OASF. DLS analysis of STIM1-OASF (light blue) (A), STIM1-
2βOASF (red) (B), STIM2-OASF (green) (C), and STIM2β-OASF (purple) (D), Data
acquired in the presence of 25 mM CaCl2 are shown as open symbols. Data are means ± SEM
of n = 3 separate protein preparations.
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Figure 3.8. The 2 insertion promotes similar hydrodynamic distribution as STIM1-2-
OASF and STIM2-OASF conformations. Data are replotted from Figure 3.7.
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3.7 The 2 insertion does not alter OASF quaternary 
structure 
At dilute protein concentrations and low temperatures STIM1-OASF is dimeric (Muik et 
al., 2011; Thompson et al., 2018). Having discovered that the 2β insert restricts the 
aggregation of the STIM2β-OASF and promotes a similar distribution of particle sizes in 
the STIM1-2-OASF and STIM2-OASF contexts, I next probed the quaternary structure 
of the smallest particle size detectable in solution using SEC-MALS experiments and the 
effect Ca2+ has on this quaternary structure. SEC-MALS showed that the elution volume 
of STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF is not altered by 
the presence of 25 mM CaCl2. The MALS-determined molecular weights of all the OASF 
proteins indicated dimeric quaternary structures in both the presence and absence of 25 
mM CaCl2 (Figure 3.9A, Figure 3.9B, Figure 3.9C and Figure 3.9D). Specifically, based 
on the theoretical molecular weights of the monomer subunits, the stoichiometries of 
STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF were 2.2, 2.0, 2.0 
and 2.0, respectively (Table 3.4). In the presence of Ca2+ the stoichiometries was 2.0 for 
all proteins. Interestingly, the STIM1-2-OASF protein showed an earlier elution volume 
compared to the STIM1-OASF counterpart, and this earlier elution volume was more 
similar to STIM2-OASF and STIM2-OASF (Table 3.4).  
Taken together, the SEC-MALS data revealed all OASF proteins in the presence and 
absence of Ca2+ maintain a dimeric stoichiometry. However, STIM1-OASF elutes at later 
elution volumes suggesting a more compact (i.e. small) OASF conformation compared to 
STIM1-2-OASF, STIM2-OASF and STIM2-OASF.  
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Figure 3.9. STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF
form dimers in the presence and absence of Ca2+. SEC-MALS analysis of STIM1-
OASF (A), STIM1-2-OASF (B), STIM2-OASF (C), and STIM2-OASF (D) The
elution profiles acquired in the presence of 25 mM CaCl2 are shown as dashed black
lines in each panel. The MALS-determined molecular weights calculated for each
elution peak are shown under the peaks as closed circles. A summary of the elution
volumes, molecular weights and stoichiometries is given in Table 3.4. The SEC-
MALS was performed using a Superdex 200 increase 10/300 GL at 10 °C.
68 
 
Table 3.4: Summary of the SEC-MALS data of STIM1-OASF, STIM1-2-OASF, 
STIM2-OASF and STIM2-OASF proteins 
(a) represents SEC-MALS experiments were conducted in 25 mM Ca2+, - represents SEC-MALS 
experiments conducted in Ca2+ free conditions  
(b) Superdex 200 chromatography column was used to filter and elute protein based on size 
(c) Stochiometric ratio was calculated by dividing the calculated MALS value by the theoretical monomer 
mass 
  
Protein Ca2+ (a) Elution(b) 
Volume 
(mL) 
MALS Molecular 
Weight (kDa) 
Stochiometric 
Ratio(c) 
STIM1-OASF - 13.59 ± 0.14 67.6 ± 1.4 2.18 
STIM1 2-OASF - 12.69 ± 0.05 64.9 ± 1.7 2.02 
STIM2-OASF - 12.69 ± 0.02 61.4 ± 1.3 1.98 
STIM2-OASF - 12.85 ± 0.02 60.8 ± 0.2 1.96 
STIM1-OASF + 13.55 ± 0.01 62.3 ± 3.7 2.00 
STIM1 2-OASF + 13.03 ± 0.3 63.0 ± 1.3 1.96 
STIM2-OASF + 12.76 ± 0.08 61.8 ± 2.1 1.99 
STIM2-OASF + 12.87 ± 0.2 61.3 ± 1.6 1.97i 
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3.8 The 2 insertion does not alter gross OASF structure  
Having discovered that the 2 insertion decreases the level of -helicity but does not alter 
the quaternary structure of STIM1-OASF or STIM2-OASF under stable and dilute 
conditions, I next assessed whether the 2 variation causes gross structural changes to the 
domain using SAXS. The SAXS data was also acquired at 4 °C to stabilize the dimer 
conformation. High quality SAXS information requires high concentration and low levels 
of protein aggregation to yield scattering profiles which show a high level of scattering 
intensity after subtraction of buffer controls. Unfortunately, I found that STIM1-OASF, 
STIM1-2-OASF, STIM2-OASF and STIM2β-OASF had a maximum achievable protein 
concentration of ~0.8 – 1.1 mg mL-1. Above this concentration the samples exhibited a 
high level of protein precipitation. Thus, all SAXS data was acquired at this relatively low 
concentration range, yielding noisy scattering profiles, particularly evident at higher s 
values (vector magnitudes). 
Nevertheless, STIM1-OASF provided the SAXS profile with the least variability at higher 
s values (Figure 3.10A). From this data, the radius of gyration (Rg) was determined using 
a Guinier plot using only low s values (Figure 3.10B). The maximum particle diameter 
(Dmax) was estimated to be 11.40 nm from the Porod distance distribution plot (Figure 
3.10C). Similar analyses for the STIM1-2-OASF protein revealed an Rg and Dmax of 2.94 
nm and 11.10 nm, respectively (Figure 3.10D, Figure 3.10E and Figure 3.10F). The 
STIM2-OASF and STIM2-OASF proteins showed Rg values of 2.96 and 3.43 nm, 
respectively, and the Dmax values from the Porod distribution functions were 11.35 and 
13.20 nm, respectively (Figure 3.11A, Figure 3.11B, Figure 3.11C, Figure 3.11D, Figure 
3.11E and Figure 3.11F).  
Next, I used the scattering profiles and Dmax from the Porod distribution plots to calculate 
low resolution bead models of the various OASF proteins using DAMMIF. Interestingly, 
for the STIM1-OASF data, two possible conformations were reconstructed. One 
conformation showed a single extension, which presumably corresponds to interacting 
CC1 domains (see Figure 1.2), while the second conformation showed two separate CC1 
domains (Figure 3.12A and Figure 3.12B). The bead models for the STIM1-2-OASF, 
70 
 
STIM2-OASF and STIM2-OASF all exhibited very similar conformations as the STIM1-
OASF model with the single extension (Figure 3.12C, Figure 3.12D and Figure 3.12E). 
Overall, the SAXS data revealed Rg values in-line with the smallest distribution of Rh 
measured by DLS. Additionally, the 2 insert did not cause major changes in either Rg or 
Dmax, suggesting more CAD specific structural changes caused by the variation in both the 
STIM1-OASF and STIM2-OASF contexts. Consistent with this notion, the reconstructed 
bead models for all OASF proteins showed similar accessible global conformations with 
or without the 2 insertion.   
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Figure 3.10: The 2 insertion causes only minor changes to the STIM1-OASF Rg and 
Dmax. (A) SAXS scattering profile of STIM1-OASF acquired at 1.04 mg mL-1. (B) Guinier 
plot of STIM1-OASF using only low s values. (C) Porod distance distribution functions of 
STIM1-OASF. (D) SAXS scattering profile of STIM1-2-OASF acquired at 0.86 mg mL-
1. (E) Guinier plot of STIM1-2-OASF using only low s values. (F) Porod distance 
distribution functions of STIM1-2-OASF. In (A) and (D), the scattering profile 
reconstructed from the Porod distribution plot is shown in red while the profile 
reconstructed from the DAMMIF model (see Figure 3.12 below) is shown in yellow 
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Figure 3.11: The 2 insertion causes only minor changes to the STIM2-OASF Rg and 
Dmax. (A) SAXS scattering profile of STIM2-OASF acquired at 1.05 mg mL-1. (B) Guinier 
plot of STIM2-OASF using only low s values. (C) Porod distance distribution function of 
STIM2-OASF. (D) SAXS scattering profile of STIM2-OASF acquired at 1.10 mg mL-1. 
(E) Guinier plot of STIM2-OASF using only low s values. (F) Porod distance distribution 
functions of STIM2-OASF. In (A) and (D), the scattering profile reconstructed from the 
Porod distribution plot is shown in red while the profile reconstructed from the DAMMIF 
model (see Figure 3.12 below) is shown in yellow.   
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Figure 3.12. SAXS-derived bead models suggest similar global structures accessible
by STIM1-OASF, STIM1-2-OASF, STIM2-OASF and STIM2-OASF. DAMMIF-
derived bead of STIM1-OASF (conformation 1) (A), STIM1-OASF (conformation 2)
(B), STIM1-2-OASF (C), STIM2-OASF (D), and STIM2-OASF (E). The
reconstructed scattering curves based on the DAMMIF structures are plotted on the
respective scattering profiles shown in Figure 3.10 and 3.11.
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3.9 The 2 insertion inhibits OASF function in SOCE 
independent of the STIM2 context 
The VAASYLIQ insertion has only been identified in STIM2 homologues. Additionally, 
the ability of STIM2 to inhibit Orai1 activation in SOCE has already been established by 
several studies (Miederer et al., 2015; Rana et al., 2015). Further, even without the 2 
insert, STIM2 is known to couple to Orai1 and activate SOCE less efficiently than 
STIM1(Oh-Hora et al., 2008; Wang et al., 2014; Zhou et al., 2016). Thus, it remains 
unknown whether the underlying inhibitory mechanism by 2 is a result of insertion into 
the context of the STIM2 which is a weak SOCE activator or whether the inhibition is due 
the ability to alter the intrinsic biophysical and conformational properties of OASF required 
for inducing SOCE. 
Having shown that the 2 insert similarly decreases the -helicity and thermally 
destabilizes STIM1-OASF and STIM2-OASF and revealing that all OASF proteins access 
similar global structures, I next assessed whether the 2 insert must be in the STIM2 
context to exert an inhibitory effect on SOCE. First, I introduced the 2insert into full-
length mCherry tagged STIM1 (mCh-STIM1) by site directed mutagenesis. Subsequently, 
HEK293 cells stably expressing YFP tagged Orai1 (YFP-Orai1) (Choi et al., 2017; Gui et 
al., 2018; Zhu et al., 2018) were transfected with WT mCh-STIM1 or mCh-STIM1-2. 
After loading the cells with Fura-2, SOCE was assessed using ratiometric fluorescence 
spectroscopy. Cells were initially bathed in HBSS medium in the absence of Ca2+. Upon 
addition of thapsigargin (TG) (2 μM), the transient release of Ca2+ from the ER was not 
significantly different between the empty mCh-vector control, mCh-STIM1 and mCh-
STIM-2 groups (Figure 3.13A and Figure 3.13B). After 500 s of passive ER Ca2+ store 
depletion, 2 mM of Ca2+ was added the cell bathing medium. As expected, cells expressing 
mCh-STIM1 showed a significantly higher level of SOCE than the empty vector 
expressing cells (i.e. Fura2 ratio of 1.56 ± 0.04 compared to 1.23 ± 0.1, respectively) (*p 
<0.05) (Figure 3.13A and Figure 3.13C). When Ca2+ was added back to cells expressing 
mCh-STIM1-2β, the Fura2 ratio was not significantly different than the empty vector 
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expressing cells (i.e. 1.23 ± 0.03 compared to 1.21 ± 0.1, respectively) (p > 0.05) (Figure 
3.13A and Figure 3.13C). 
To confirm that the differences in SOCE mediated by mCh-STIM1 and mCh-STIM1-2 
were not due differences in expression levels, I obtained mCh and YFP fluorescence 
emission spectra of the cell suspensions used for the Fura measurements. Our laboratory 
has previously shown that mCh-STIM1 fluorescence correlates with proteins levels 
assessed by western blots (Zhu et al., 2018). As expected mCh-STIM1 and mCh-STIM1-
2 expression levels were not significantly different from one another, while the empty 
mCh-vector control showed higher fluorescence since it was not targeted to the ER (Figure 
3.13D). Similarly, YFP fluorescence was not different among the three groups tested 
(Figure 3.13E).  
Collectively, these results show that incorporating 2β insert into the OASF region of full 
length STIM1 perturbs SOCE activity, as previously observed for STIM2, suggesting that 
the VAASYLIQ insertion perturbs the structure, independent of the homologue-specific 
amino acid sequence.  
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Figure 3.13: The 2insertion perturbs the SOCE-inducing function of STIM1 in the 
full-length molecular context. (A) Representative Fura-2 fluorescence traces of SOCE 
recorded in mCh-STIM1 (blue), mCh-STIM1-2β insert (red) and empty mCh-vector (grey) 
expressing HEK293 cells also stably expressing YFP-Orai1. The data was normalized by 
plotting F/F0 to determine the maximum Fura-2-ratio after TG addition and Ca2+ addback. 
(B) Maximal ER Ca2+ release taken as the maximum Fura-2 ratio after TG addition. (C) 
Maximal SOCE taken as the maximum Fura-2 ratio after Ca2+ addback. (D) mCh 
fluorescence levels of cell suspensions. (E) YFP fluorescence levels. Statistical analysis 
was conducted using a One-way ANOVA with Tukey’s multiple comparisons test. All data 
are means ± SEM of n=4 separate transfections.   
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4 Chapter 4: Discussion 
4.1 Summary 
The CAD domain, which is composed of CC2 and CC3 in STIM1 and STIM2, contains all 
the machinery required to activate Orai1-composed Ca2+ channels on the PM. However, 
CC1 is required to induce the conformational rearrangement within the STIM1 cytosolic 
domains which extends the protein to bridge the distance between the ER and PM and 
allow for direct contact between CAD and Orai. Thus, the entire OASF region is critical 
for intracellular Ca2+ homeostasis mediated by SOCE. Indeed, previous studies have 
demonstrated that heritable mutations in the STIM1 CAD and CC1 regions lead to disease. 
Disease pathologies can result from a gain of function, as is caused by R304W in CC1 
which constitutively increases SOCE (Misceo et al., 2014; Morin et al., 2014) or a loss of 
function, as is caused by R429C in CC3 which prevents the activation of STIM1 and SOCE 
(Maus et al., 2015). Remarkably, cells have also evolved a mechanism to modulate CAD 
function through phosphorylation of T389 in CC2. The effects of this phosphorylation 
within CAD can be artificially mimicked through introduction of the T389E mutant which 
inhibits STIM1 activity (Thompson & Shuttleworth, 2015; Thompson et al., 2018).  
Alterative splicing is another evolutionary mode of SOCE regulation, as the retention of 
an 8-amino acid residue stretch (i.e. 2 insert) in the CAD domain of STIM2 gives rise to 
an inhibitory isoform known as STIM2. (Miederer et al., 2015; Rana et al., 2015). To 
elucidate how the 2 insert converts the CAD domain into an inhibitor of SOCE, I 
generated site-specific mutagenic constructs to incorporate the 2β insert into H. sapiens 
STIM1 and STIM2 OASF. I used the entire OASF region in my studies since it includes 
all the CC domains, each of which play an important role in the activation mechanism of 
STIMs. My structural studies using far-UV CD spectroscopy showed that the 2 insert 
decreases the -helicity and destabilizes OASF. I also found using ANS binding 
experiments that the 2 insert increases the exposed hydrophobicity of OASF and the 
structural sensitivity of OASF to high concentrations of Ca2+. Based on my SEC-MALS 
data, these changes in secondary structure and hydrophobic exposure do not affect the 
assembling dimer quaternary structure of OASF. Further, my low resolution SAXS 
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analysis suggests similar overall shapes are accessible by OASF proteins with and without 
the 2 insert. Finally, using Fura-2 cytosolic Ca2+ measurements, I found that the 2 insert 
markedly inhibits STIM1 activity and SOCE, as previously observed for STIM2. 
Collectively, my work demonstrates that the 2 insert inhibits STIM activity by 
incorporation into the OASF structural context, independent of the STIM2-specific 
sequence of amino acids making up OASF. 
4.2 OASF structure, variations and function 
Previous studies have identified regulatory modifications in the OASF region which result 
in lower SOCE activity. The 2insert, is mutated between G379 and A380 in STIM1 
which located in close proximity to T389, where the phosphorylation of this residue 
effectively inhibits store-dependent CRAC channel and promotes store-independent ARC 
channel activity (Thompson & Shuttleworth, 2015). The negatively charged properties of 
the phosphate group can be mimicked through a single point mutation (i.e. T389E), also 
inhibiting SOCE. Interestingly, the T389E mutation increases the -helicity of STIM1-
OASF (Thompson et al., 2018). Consistent with the increase in -helicity, the 
phosphomimetic mutant also promotes higher thermal stability. The stabilization of 
STIM1-OASF is thought to be due to an extension of the CC2 helix which uniquely allows 
for the precise activation store-independent ARC channels and no activation of CRAC 
channels. Conversely, my work has shown that 2insert decreases -helicity and thermal 
stability of STIM1-OASF (Figure 3.1 and Figure 3.2). This observation is consistent with 
the R429C mutation that results SCID-like syndrome which decreases the -helicity and 
stability of OASF, thereby inhibiting STIM1 and SOCE activity (Maus et al., 2015).  
In SOCE, dimeric STIM1 undergoes a structural change to expose the CAD region which 
gates Orai1-composed CRAC channels at the ER-PM junctions. A previous study has 
shown that a concatenated CAD dimer containing the F394H point mutation in each 
subunit completely blocks the ability of this homodimer to induce SOCE (Zhou et al., 
2015). However, if the mutation is introduced into only one of the monomers, Orai1 
binding and activation remains unaffected, suggesting unimolecular coupling between 
STIM1 and Orai1 (Zhou et al., 2015). Using HEK cells, Zhou et al. also compared the 
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Orai1 activation using a STIM1/STIM2 heterodimers and found that they were able to 
couple with activate Orai1 channels. This finding suggests that homodimers of STIM2 
are necessary to induce complete SOCE inhibition. However, this work by Zhou et al. is 
inconsistent with the data presented by Rana et al. and Miederer et al., where both groups 
independently found STIM1/STIM2and STIM2/STIM2 heterodimers were unable to 
activate Orai1-composed CRAC channels(Miederer et al., 2015; Rana et al., 2015). It 
should also be noted that Zhou et al. speculated that the 2insert induces an -helical 
extension (Zhou et al., 2015); however, my work clearly shows that incorporating the 
2insert into OASF significantly reduces -helicity in both the STIM1 and STIM2 context 
(Figure 3.1).  
One of the steps in SOCE is the conformational change of OASF from a compact inactive 
state to an extended activated state (Muik et al., 2011). This transition exposes the CC2-
CC3 (i.e. CAD) region to the PM where interactions can occur with Orai1 subunits 
resulting in CRAC gating and activation. Based on my SEC data, the extended 
conformation was adopted by STIM1-2 insert and STIM2-OASF (Figure 3.9). 
Interestingly, STIM2-OASF, but not STIM1-OASF, was also in the extended 
conformation, as indicated by the earlier elution volumes. Therefore, SOCE inhibition by 
the 2 insert is likely not attributable to the inability for STIM1 to transition to the extended 
state; rather, the inhibition occurs downstream of the conformational extension.  
Several models of SOCE inhibition by the 2 insert have been suggested. Homology 
modeling has suggested that the 2insert alters the self-association of CAD such that it 
cannot form stable dimers, and this deficiency may underlie the inability to interact with 
Orai1 channels (Miederer et al., 2015). However, my data shows that the dimer nature of 
OASF remains intact (Figure 3.9). Another model suggests that STIM2precludes binding 
of STIM1 or STIM2 to Orai1 subunits through steric hinderance when cytosolic Ca2+ ions 
are present essentially inducing a negative feedback process to halt SOCE (Miederer et al., 
2015). My findings show that Ca2+may be driving a state of aggregation (Figure 3.7) 
through promoting greater exposed hydrophobicity (Figure 3.3) within OASF. The 
aggregation of STIM1 and STIM2 in the presence of Ca2+ may prevent coupling between 
83 
 
CAD and Orai1 by burying Orai1 binding site. Interestingly, Rana et al. showed that SOCE 
inhibition by the 2 insert is sensitive to variations in the 8-residue insert sequence(Rana 
et al., 2015)Thus, another possible mechanism is a more active inhibition, whereby 
STIM2adopts a conformation which delivers inhibitory signals through interactions with 
Orai1 (Rana et al., 2015). This type of inhibition would be sequence-specific, consistent 
with the ability of mutations in this region to reduce the effects of inhibition.  
The 2insert is found at residues 383 - 391 in STIM2however, it would be found at 
residues 379 - 387 when/if naturally incorporated into STIM1 (Figure 1.3). There has been 
extensive structural characterization in the STIM1 CC1-CC2 region using solution NMR 
spectroscopy and SAXS. Previous studies showed that the CC1-CC2 structure exhibits two 
extended helices called residues 313 - 340) and residues 344 - 382) that are linked 
together by a short loop called L1 (residues 341 – 343) (Stathopulos et al., 2013; X. Yang 
et al., 2012). This CC1-CC2 structure showed that monomers form an antiparallel 
symmetric dimer through ’, ’ and C-terminal L1’ interactions. An 
additional solution structure of CC1-CC2 in complex with the human Orai1 C-terminal 
domain revealed that many of the CC2 (i.e. 2) residues play vital roles in directly 
interacting with Orai1. These 2 residues form hydrophobic cleft which is encircled by an 
electropositive surface potential. Both hydrophobic and electrostatic interactions are 
required for binding to Orai1 C-terminal domain. The Orai1 binding region on STIM1 
formed by the CC2 helices is termed the STIM-Orai association pocket (SOAP). Based on 
the solution NMR structure of the STIM1 CC1-CC2:Orai1 C-terminal domain complex, 
the 2 insert is localized just upstream of residues intimately involved in forming the 
electropositive potential. Thus, 2 insert may, at least in part, prevent binding to Orai1 by 
disrupting the electropositive potential of this region in STIM molecules.  
4.3 Ca2+ and OASF function 
To regulate Ca2+ influx and minimize risk of toxicity associated with diseases, STIM1 
contains 7 highly conserved negatively charged residues (i.e. DDVDDMDEE) called the 
CRAC modulatory domain (CMD). This sequence is located downstream of the CC 
domains (i.e. 474 – 485) and is the first putative Ca2+ binding site identified in the STIM1-
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C terminus (Derler et al., 2009). Interestingly, Derler et al. showed that STIM1 mutants 
that lacked the CMD region exhibited a significantly reduced inactivation of Orai/CRAC 
by Ca2+. They proposed that Ca2+ binding induces a conformational change within the 
STIM1 cytosolic domain that perturbs the interaction with Orai1 and promotes Ca2+-
binding-dependent inactivation. Consistent with the Derler et al. work, another study that 
neutralized CMD by converting the Glu and Asp residues to Ala showed a marked 
reduction in Ca2+-dependent inactivation not only when coupled to Orai1, but also when 
bound to Orai2 and Orai3 (Lee et al., 2009). These two studies conclude that the 
inactivation of Orai1 currents is preserved so long as the negatively charged residues in 
this region are present. Thus, the CMD play a role in providing a negative signal to Ca2+ 
entry through promoting fast Ca2+-dependent inactivation of CRAC channels. Remarkably, 
my ANS data shows that incorporating 2insert results in greater exposed hydrophobicity 
(Figure 3.3). Importantly, the marked increase in exposed hydrophobicity is further 
exacerbated with the subsequent addition of Ca2+ which drives a conformational change 
associated with more exposed hydrophobic regions for STIM1-OASF and STIM2-OASF. 
My findings support the notion put forward by Derler et al. that Ca2+ induces a 
conformational change. 
The oligomerization of the STIM cytosolic domains is one of the crucial steps of SOCE 
activation as it leads to the formation of discrete puncta, allowing for Orai co-clustering. 
Previous studies have shown that the STIM1 cytosolic C-terminal domains are sufficient 
to activate Orai1 currents, independent of store-depletion. Interestingly, confocal FRET 
analysis has shown that the STIM1 fragments (i.e. 233-450/474) exhibited the highest level 
of self-association and co-clustering with Orai1 in HEK293 cells(Zhou et al., 2015). This 
finding lead to the identification of residues 420-474 playing an important in the 
homomerization of the STIM1 cytosolic domains (Muik et al., 2009). This 420-474 region 
is located upstream of the putative Ca2+ binding site (i.e. residue 474-485). Thus, I 
speculate that Ca2+ binding to the negatively charged residues could result in a 
conformational change which affects the exposure of this homomerization domain. An 
independent study confirmed the CC regions play a role in mediating STIM1 
oligomerization (Covington et al., 2010). By using coimmunoprecipitation, fluorescence 
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photobleaching and energy transfer techniques, they showed that STIM1 mutants lacking 
the cytosolic domains could not form stable oligomers in response to ER Ca2+ store 
depletion. Furthermore, they demonstrated that truncating STIM1 at CC2 resulted in no 
puncta formation or Orai1 recruitment after ER Ca2+ store depletion. However, adding back 
the residues making up CC3 (i.e. residues 392-448) permitted the formation of stable, 
higher-order STIM1 oligomers in response ER Ca2+ store-depletion. Thus, CC2 acting as 
the mediator and CC3 acting as the homomerization domain were shown to be important 
factors which function in tandem to mediate the formation STIM1 oligomers and promote 
SOCE.  
My data shows that increased ANS binding at higher Ca2+ concentrations could be due to 
a Ca2+-binding induced conformational change to OASF. Based on the findings presented 
by Covington et al. and Muik et al., these Ca2+ binding induces structural changes in OASF 
are likely to affect oligomerization and Orai1 binding due to the close proximity to CC3 
(required for homomerization) and the proximity to CAD which is necessary for Orai1 
binding. Therefore, the Ca2+ binding induced aggregation I observed for all constructs 
(Figure 3.7) is consistent with the conformational change induced by Ca2+ binding affecting 
the homomerization domain (i.e. CC3). It is important to note that the increased 
aggregation is counterintuitive given that oligomerization promotes STIM1 activation; 
however, I speculate that the Ca2+ induced aggregated state of OASF is different than the 
conformation required for Orai1 activation. 
In the absence of Ca2+, my data shows increased ANS binding in the OASF proteins 
containing 2 This increased ANS binding may be associated with the reduced -helicity 
observed when the 2 is incorporated into STIM1-OASF and STIM2-OASF (Figure 3.1). 
Thus, the 2 insert may promote a localized unfolding in OASF which would lead to more 
ANS binding sites. The idea of a localized structural change induced by 2 insert on both 
STIM1 and STIM2 is consistent the SEC-MALS data where all OASF proteins remained 
dimeric (Figure 3.9). Furthermore, for STIM1-OASF, there also appears to be a marked 
change in elution volume, even though the protein remains dimeric. This suggests that for 
STIM1-OASF the localized unfolding may promote the extended conformation as has been 
observed in previous studies (Muik et al., 2011). Since the elution volume of STIM1-2-
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OASF is the same as STIM2-OASF and STIM2-OASF, both STIM2-OASF and STIM2-
OASF may already adopt the extended conformation. 
My SAXS data supports the notion that the STIM1-OASF conformation may be subtly 
different than STIM1-2-OASF, STIM2-OASF and STIM2OASF since the bead model 
reconstruction shows two distinct conformations for STIM1-OASF: one with the CC1 
domains separated and one conformation where the CC1 domains are interacting (Figure 
3.12). After the 2 insertion, the STIM1-2-OASF bead model exhibits a conformation 
similar to STIM2-OASF and STIM2-OASF. Interestingly, my STIM1-OASF 
reconstructed bead model with the CC1 regions separated bares a striking resemblance to 
the SAXS model reconstructed from STIM1 in a previous study (Cui et al., 2013). The 
STIM1-OASF (i.e. 234-491) used in my study spanned all three CC regions, while the 
previous study used a cytosolic STIM1 protein composed of residues 254-504. Despite this 
reassuring similarity between my work and the previously published SAXS data, my SAXS 
data overall was poor quality and further structural studies are required to more precisely 
compare the gross structures of OASF and perturbations caused by the 2 insert (see 
below). 
4.4 The 2insert inhibits SOCE in the context of the 
OASF structure 
STIM2 has been demonstrated in past studies to be inhibitory to SOCE which has been 
proposed to act through heterodimerization with STIM1 and STIM2 (i.e. STIM1/STIM2 
and STIM2/STIM2 respectively). Using total internal reflection fluoresence (TIRF) 
microscopy, Miederier et al. showed that STIM2exhibited impaired interactions with 
Orai1 as there was reduced co-localization between STIM2and Orai1 in HEK239 
cells(Miederer et al., 2015). Furthermore, Rana et al. showed that while overexpression of 
STIM2 increases NFAT-translocation to the nucleus even in the absence of TG, 
overexpressed STIM2 with Orai1 strongly inhibited TG-mediated NFAT translocation, 
consistent with an inhibitory role in SOCE. NFAT translocation to the nucleus is dependent 
on SOCE activation. Remarkably, both groups showed that STIM2 can heterodimerize 
with STIM1 and STIM2 and postulated that inhibition is occurring due to interactions with 
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the STIM homologues. To test for heterodimerization, Rana et al. co-transfected STIM1 
and STIM2lacking the polybasic domain such that trapping at the PM was dependent on 
CAD interactions with Orai1. They showed that when co-expressed, STIM2 was recruited 
to Orai1 through sufficient interactions with STIM1. Similarly, Miederier et al. co-
expressed STIM2 with STIM2 in HEK293 cells and found a significant reduction in Ca2+ 
inward currents(Miederer et al., 2015).  
STIM2 is a slower activator of SOCE and has a weaker efficacy of Orai1 activation 
(Brandman et al., 2007; Wang et al., 2014; Zhou et al., 2009). In relation to the kinetics of 
STIM2, to determine whether the 2insert is inhibitory because it is already found in the 
context of a weak SOCE activator (i.e. STIM2), I tested the inhibition in the context of 
STIM1, a robust SOCE activator. Remarkably, introducing the 2 insert into full length 
STIM1 resulted in a significant reduction in SOCE activity as apparent in the reduced Fura-
2 ratio (Figure 3.13). My findings suggest that the 2 insert perturbs OASF conformation 
and function making OASF incapable of activating SOCE, independent of the STIM2 
context of weaker Orai1 binding affinity and SOCE activation efficiency. 
4.5 Conclusions 
Ca2+ is an important regulatory ion in nearly all physiological processes. Regulation of 
cellular Ca2+ through the actions of STIM1 and STIM2 proteins maintains basal Ca2+ levels 
and allows cells to signal fluxes required for life and death processes. Mutations within the 
cytosolic domain of STIM1 affect SOCE activity by overactivation of CRAC channels 
such as via the R304W which leads to Stormorken Syndrome (Misceo et al., 2014; Morin 
et al., 2014). Disease can also be caused by mutations in STIM1 such as R429C which 
result in a SCID-like pathophysiology. Alterative splicing is a mechanism of Ca2+ 
regulation which is introduced in cells at the transcriptional level. STIM2β is a splice 
isoform which inhibits SOCE (Miederer et al., 2015; Rana et al., 2015). Collectively, my 
biophysical data revealed that the 2β insert reduces the -helicity of the OASF region, 
promotes an alternative conformation with greater exposed hydrophobicity and increases 
the sensitivity of the region to Ca2+. Furthermore, the insertion into the robust SOCE 
activator of STIM1 results in complete inability to activate SOCE, as was previously 
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observed for the milder SOCE activator STIM2, suggesting that this 8-amino acid insert is 
inhibitory outside of the STIM2 context (Figure 4.1). 
It is interesting to speculate that STIM2heterodimerization with STIM1 or STIM2 may 
add an additional layer of regulation to this complex, but physiologically vital process. 
Alterative splicing is a phenomenon that can give rise a plethora of isoforms from a single 
gene. My work shows that understanding the differences in the structural mechanisms of 
function between isoforms may provide a foundation for the future development of new 
therapies for disease.  
4.6 Future Directions and Limitations 
Solution SAXS experiments on STIM1-OASF, STIM1-2-OASF, STIM2-OASF and 
STIM2-OASF were unable to reveal precise structural differences between the OASF due 
to the low-resolution technique which was also exacerbated by poor quality data. However, 
my work showed that the 2 insert decreases the overall OASF -helicity and induces a 
conformation with greater exposed hydrophobicity (Figure 3.1, Figure 3.3 and Figure 3.4). 
Thus, future studies should work toward increasing the resolution of the structural data to 
provide new insights on the basis for 2 insert-mediated inhibition at the atomic level. 
Previous studies have used solution NMR spectroscopy to assess various structural aspects 
of the CC region of STIM1-OASF (Fahrner et al., 2018; Rathner et al., 2018; Stathopulos 
et al., 2013), and this approach may be useful to assess the structural effects of the 2 insert 
with higher precision. 
In Stromorken syndrome, the R304W in CC1 results in an overactivation of SOCE leading 
to symptoms such as muscle fatigue and thrombocytopenia (Fahrner et al., 2018; Morin et 
al., 2014). On other hand, STIM2 robustly inhibits SOCE (Miederer et al., 2015; Rana et 
al., 2015). My functional data using HEK293 cells have shown incorporation of the 2 
insert into STIM1 renders STIM1 incapable of eliciting SOCE. To gain additional insight 
into the inhibitory mechanisms of the 2β insert, it would be interesting to determine if 
incorporating the 2β insert into a STIM1-OASF containing the R304W can abolish the 
constitutive activation of SOCE. Inhibition of SOCE in the STIM1-R304W context by the 
89 
 
2 insert may help in the development of a new treatment strategy for Stromorken 
syndrome patients through exploiting the 2 inhibition mechanism on OASF. To determine 
whether the 2 heterodimers are dominant SOCE inhibitors, one could attempt to 
overexpress STIM2heterodimers in an in vivo mouse model of Stormorken syndrome. 
The ability of STIM2 to inhibit the constitutive SOCE in Stormorken model mice would 
open the door to potentially treating Stormorken syndrome by altering (i.e. upregulating) 
the STIM2 expression already endogenous to vertebrates. 
There are limitations associated with biophysical aspects of this study. First, my 
experiments use isolated STIM1-OASF and STIM2-OASF outside the normal cellular 
milieu which could affect both structure and stability of the domain. There are STIM 
binding partners such as the microtubule plus-end-tracking protein-1 (EB1) (Honnappa et 
al., 2009), calnexin and two other transporters, exportin1 and transportin1 (Saitoh et al., 
2011), and many others, which can associate with STIM1 and STIM2 and possibly affect 
how the 2 insert exerts its effects. Furthermore, my biophysical studies used a segregated 
portion, OASF, from STIM otherwise composed of several other important regions which 
play a role in SOCE such as the EF-SAM domain that acts as the ER Ca2+ sensor and the 
polybasic region that interacts with the PM after conformational extension (Figure 1.2). 
These other domains may play a role in mediating stability and structure via allosteric 
and/or direct interactions.  
The basal physiological concentration of Ca2+ in the cytosol is ~100 nM and can reach as 
high as ~1-2 μM during a signaling cascade (Clapham, 2007; Kurosaki et al., 2010). I used 
25 mM Ca2+ in my ANS binding assay, far-UV CD and SEC-MALS experiments. While 
this high Ca2+ concentration promoted a maximal Ca2+ response in our in vitro experiments, 
this concentration far exceeds the upper known boundaries of Ca2+ within cells and may 
not be representative of STIM protein behavior in a physiological state.  
SAXS is a powerful tool that can used to determine certain biophysical characteristics such 
as Rg and, importantly, reconstruct a low-resolution structure using the SAX scattering 
profile. However, SAXS often requires a highly concentrated and pure protein which 
proved challenging using my OASF proteins. High concentrations (i.e. > ~ mg mL-1) 
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resulted in aggregation and precipitation with my OASF proteins. Due to the relatively low 
protein concentrations of all OASF proteins and the home source SAXS instrument used 
in the data acquisition (see Materials and Methods), the SAXS data suffered from low 
signal to noise and was, overall, of poor quality. The data was further negatively affected 
by the aggregation propensity of all samples. 
Finally, in my functional Fura 2 assay, I was working with a population of HEK293 cells 
that were stably expressing YFP-Orai1 subunits. To test SOCE, I transfected my HEK293 
cells to transiently express mCh-STIM1 and mCh-STIM1-2; however, it was not 
ascertained whether the 2insert altered the localization of the STIM1 protein. Thus, future 
studies should assess the localization of the mCh-STIM1-2 before and after ER Ca2+ 
store depletion, using TIRF microscopy.  
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(a) represents SEC-MALS experiments were conducted in 25 mM Ca2+, - represents 
SEC-MALS experiments conducted in Ca2+ free conditions  
(b) SuperDex 200 chromatography column was used to filter and elute protein based on 
size 
(c) Stochiometric ratio was calculated by dividing the calculated MALS value by the 
theoretical monomer mass 
 
                                                 
 
